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Schizophrenia (SZ) is debilitating neuropsychiatric disorder and afflicted patients 
exhibit an array of symptoms including hallucinations, delusions, flat affect, and deficits 
in cognitive functioning. Even though the functional outcome of patients with SZ is 
correlated with the severity of cognitive deficits, current therapeutics do not effectively 
improve cognitive deficits. However, there is still not a clear understanding of the 
pathophysiology underlying cognitive deficits, making it difficult to develop therapeutics 
target at the improvement of cognition in patients. The mediodorsal nucleus of the 
thalamus (MD) has been thought to play a role in cognitive control behaviors alongside 
the prefrontal cortex (PFC). This is largely due to the reciprocal connections between the 
MD and PFC, reports of MD neurons exhibiting similar task-related activity patterns 
during cognitive behaviors, and that lesions in the MD produce deficits in cognition 
similar to PFC lesions. Also, in patients with SZ the MD and PFC exhibit correlated 
reduced activation during cognitive control performance and are function disconnected 
from each other. In order to further our understanding of the pathophysiology in the MD-
PFC thalamocortical network, I trained monkeys to perform a cognitive control task that 
exposes cognitive control deficits in patients with SZ. First, I relate thalamocortical 
distributed processing and functional coupling to cognitive control by recording in the MD 
and PFC simultaneously in the healthy state. Then, I characterize the effects of NMDA 
receptor (NMDAR) blockade on thalamocortical distributed processing and functional 
coupling underlying cognitive deficits. I found that MD neurons represent cognitive 
control state similarly to PFC neurons, but that PFC state neurons contain more 
information early in the trial, while MD state neurons contain more information late in the 




neurons in the MD and PFC transmit state and response information reciprocally during 
cognitive control performance. Following NMDAR blockade, there were less MD and 
PFC neurons recruited to encode state and response information and the neurons that 
did encode task information were delayed in their recruitment. Additionally, 
representation of task state was decreased at the single neuron and population levels in 
both the MD and PFC, but to a stronger degree in the PFC than the MD, and these 
changes in state representation predicted task failure on a trial-by-trial basis more 
strongly in the MD than the PFC. Lastly, NMDAR blockade strongly attenuated 
transmission of information in local circuits in and between the MD and PFC. Overall, I 
am the first to characterize MD-PFC cellular level network dynamics underlying cognitive 
control and the effect of NMDAR blockade on this thalamocortical network that results in 
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Schizophrenia (SZ) is a neuropsychiatric disorder that is related to dysfunction 
across many neural systems, resulting in wide-ranging symptoms in afflicted patients. 
Clinically, SZ presents as a mixture of positive symptoms (e.g. hallucinations and 
delusions), negative symptoms (e.g. loss of motivation and anhedonia), and cognitive 
symptoms (e.g. impairments in executive function, working memory, and attention) in 
multiple combinations and levels of severity (American Psychiatric Association, 2013). 
Due to this extensive and heterogeneous expression of symptoms across patients, SZ is 
particularly difficult to treat. Current therapeutics, anti-psychotics (typical and atypical), 
mainly treat the positive symptoms, while leaving the other symptom categories 
relatively unimproved (Mortimer, 1997; Stip et al., 2005; Tandon, 2011; Schulz et al., 
2016). Improving cognitive symptoms, in particular, should be a main goal of treatments 
because inferior functional outcomes of patients are correlated with the severity of 
cognitive deficits (Green et al., 2000; Green, 2006; Ventura et al., 2009). Additionally, 
treatments that are targeted towards improving cognitive symptoms also improve 
negative symptoms, and vice versa (Censits et al., 1997; Schuepbach et al., 2002). 
However, as a community we are lacking an understanding of the nature of the failure of 
neural networks that produces cognitive deficits.  
Human functional neuroimaging studies have identified brain regions that exhibit 
lower activation in patients during cognitive control performance compared to healthy 




thalamus (MD) exhibit reduced functional activation in patients with schizophrenia to a 
degree that is correlated across individuals across a range of cognitive control tasks 
(Minzenberg et al., 2009), as well as reduced functional connectivity at rest (Welsh et al., 
2010; Anticevic et al., 2014b; Anticevic et al., 2014a). In addition, the integrity of white 
matter tracts linking MD to PFC (imaged with diffusion tensor imaging) is reduced in 
patients with schizophrenia relative to controls and the severity of white matter and 
working memory deficits is correlated over patients (Giraldo-Chica et al., 2018). Patients 
with schizophrenia exhibit reduced spine density in prefrontal cortex in cortical layers 
that receive thalamocortical afferents (Kolluri et al., 2005; Lewis and González-Burgos, 
2008; Glausier and Lewis, 2013; Dorph-Petersen and Lewis, 2017). This data indicates 
that the MD-PFC thalamocortical network may be a key target for treating cognitive 
control deficits in SZ. However, little is known about the role of the MD at the cellular 
level in cognitive control or the nature of information carried between the MD and the 
PFC in the healthy or disordered state.  
Studies focusing on synaptic mechanisms underlying cognitive deficits in SZ 
provide convergent evidence in animal models, control subjects, and patients that a 
defect in NMDA (n-Methyl-d-aspartate) receptor (NMDAR) mediated synaptic 
transmission may be a causal factor in clinical symptoms and cognitive deficits in SZ 
(Luby et al., 1959; Nuechterlein and Dawson, 1984; Krystal et al., 1994; Humphries et 
al., 1996; Sokolov, 1998; Olney et al., 1999; Tsukada et al., 2005; Javitt, 2007; Stone et 
al., 2007; Lisman et al., 2008; Funk et al., 2009; Jones et al., 2011; Blackman et al., 
2013; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014; 
Howes et al., 2015; Xu et al., 2015; Balu, 2016; Cheng et al., 2018). However, how 




processing is not known. Answering this question is one of the main goals of this 
dissertation. I characterize healthy state neurophysiology in the MD and PFC and relate 
pathophysiology in the MD and PFC to cognitive deficits following NMDAR blockade. 
 
Cognitive control processing in the prefrontal cortex 
Cognitive control, and a related construct, executive control, have been variously 
defined (Baddeley and Della Sala, 1996; Perner and Lang, 1999; Smith and Jonides, 
1999; Pineda, 2000), based on several characteristics (Funahashi and Andreau, 2013). 
First, cognitive control enables attention to switch toward sources of information that are 
contextually relevant. Second, cognitive control organizes behavior temporally by 
planning the series of tasks required to reach the intended goal. Third, cognitive control 
requires accessing and manipulating stored information. Fourth, cognitive control 
monitors and integrates information about internal and external states concurrently to 
select future goals. Altogether, cognitive control can be defined as the ability to select 
contextually relevant information to make and monitor flexible goal-oriented decisions 
(Miller and Cohen, 2001). By its nature, cognitive control requires the engagement of 
multiple brain regions and coordination between them, perhaps by a single structure 
(usually referred to as the central executive).  
The PFC has long been identified as likely to function as the central executive 
due to its ability to interact with, modulate, and recruit other brain regions during 
cognitive control performance. The pervasive theory of the PFC is that it plays a primary 
role in the integration of incoming information and provides top-down control on sensory 
and motor processing to flexibly map stimuli to responses and therefore coordinate 




shown that the PFC is activated during information maintenance (D'Esposito et al., 1999; 
D'Esposito et al., 2000) and response selection (Rowe et al., 2000; Rowe and 
Passingham, 2001), is functionally correlated with other brain structures such as the 
ACC to a degree that reflects response conflict (Dove et al., 2000; MacDonald et al., 
2000; Menon et al., 2001; Dreher and Berman, 2002; Braver et al., 2003; Egner and 
Hirsch, 2005; Kerns et al., 2005; Liston et al., 2006; Boschin et al., 2017), and parietal 
cortex associated with shifting attention and stimulus-response learning (Sohn et al., 
2000; Bunge et al., 2002). Additionally, damage to the human PFC causes deficits in 
context maintenance and response inhibition (Shallice and Burgess, 1991; Miller, 2000; 
Thompson-Schill et al., 2002; Gläscher et al., 2012).  
Neurophysiological recording of the non-human primate PFC (Principal sulcus, 
Brodmann’s Area 46, analogous to the dorsolateral PFC in humans) has found that 
single prefrontal neurons exhibit patterns of activity that reflect cognitive control. For 
example, neurons in the PFC encode abstract rules (Wallis et al., 2001a), categories 
(Freedman et al., 2001; Goodwin et al., 2012), and numbers (Bongard and Nieder, 2010; 
Moskaleva and Nieder, 2014), indicating that PFC neurons encode abstract state 
variables that can provide control signals needed to flexibly adjust responses to stimuli 
as a function of context. Neural signals reflecting cognitive control are typically found not 
only in prefrontal cortex but the cortical association areas to which prefrontal cortex 
projects. For example, the object category of a visual stimulus is encoded by prefrontal 
and inferotemporal neurons in parallel (Freedman et al., 2003) and the rule-dependent 
spatial category of a visual stimulus is jointly encoded by the activity of prefrontal and 
posterior parietal neurons (Crowe et al., 2010). Likewise, the number of items in a visual 




parietal neurons (Nieder and Miller, 2004; Vallentin et al., 2012). Finally, abstract rules 
are encoded by prefrontal, inferotemporal and striatal neurons concurrently (Muhammad 
et al., 2006). These data indicate that the abstract representations on which cognitive 
control is based exist as neural representations that are distributed across prefrontal 
cortical networks. Moreover, under conditions that rules change and the mapping from 
stimuli to categories must rapidly adapt, prefrontal neurons transmit information to 
posterior parietal neurons (Crowe et al., 2013a), reflecting the influence of prefrontal 
cortex on distributed processing in large-scale brain networks.  
In addition to cognitive control, PFC has a well-established role in working 
memory. PFC neurons exhibit persistently elevated activity during the working memory 
period of delayed response tasks as a function of the item stored in working memory 
(Fuster, 1990; Funahashi et al., 1993b; Funahashi et al., 1993a; Chafee and Goldman-
Rakic, 1998; Goldman-Rakic, 1999). Although often discussed as separate functions, 
working memory is necessary to maintain rules while the brain combines and evaluates 
new information with internal states to select the correct rule-dependent response 
(D'Esposito et al., 1999; D'Esposito et al., 2000; Braver et al., 2003; Bunge et al., 2003; 
Thompson-Schill et al., 2005). This process becomes particularly salient when 
confronted with conflicting behavioral options. Therefore, working memory and cognitive 
control are related constructs. The literature regarding the role of the PFC in cognitive 
control is extensive and supports the theory that PFC implements cognitive control by 
modulating operations across multiple brain areas in distributed networks.  
 




Interactions between PFC and target structures that receive PFC input is not 
limited to corticocortical interactions. The involvement of the thalamus in cortical 
processing of information, particularly during cognition, has been a topic of a long-
standing theory for thalamocortical projections. In this theory, the thalamus is split into 
two distinct classes of nuclei based on the information they carry, their cortical targets, 
and their cortical inputs (Sherman and Guillery, 1996, 2002; Guillery and Sherman, 
2011; Sherman and Guillery, 2011; Mitchell et al., 2014). First order thalamic nuclei (like 
the lateral geniculate nucleus) relay sensory information from the periphery to primary 
sensory cortical targets, whereas higher order thalamic nuclei (like the MD) are 
extensively interconnected via reciprocal projections with association cortex. In this 
theory, ‘driver’ and ‘modulator’ projections are distinguished. ‘Driver’ inputs convey the 
sensory, motor, or cognitive information relayed through the thalamus. ‘Modulator’ inputs 
influence this transmission. Higher order thalamic nuclei receive their driver inputs from 
layer V of association cortical areas, and their modulator inputs from layer VI (Sherman 
and Guillery, 1996, 2002; Rovó et al., 2012). Modulator inputs predominate over drivers 
in higher order thalamic nuclei (Wang et al., 2002). Higher order thalamic nuclei send 
driver inputs to layer IV and modulatory inputs to layer III of association cortex 
(Sherman, 2012). By projecting to areas other than those providing their input, higher 
order thalamic nuclei can serve to relay information from one cortical association area to 
another (Sherman and Guillery, 2011). 
Recently, the MD has been identified as a likely higher-order thalamic nucleus 
because it is reciprocally connected with the PFC, MD lesions result in PFC-like 
cognitive deficits, and MD neurons exhibit activity patterns that reflect cognitive functions 




Chakraborty, 2013; Mitchell et al., 2014; Mitchell, 2015; Parnaudeau et al., 2018). 
Functional imaging studies in humans indicate that MD is activated during the delay 
period of working memory tasks and at the times that subjects receive negative 
feedback in Wisconsin Card Sorting Task, which is used to adjust cognitive strategies 
(Elliott and Dolan, 1999; de Zubicaray et al., 2001; Monchi et al., 2001). Therefore, the 
MD appears to be functionally recruited along with the PFC to mediate cognitive control. 
However, there is still much to be explored as to the nature of the involvement of the MD 
in cognitive control particularly at the cellular level.  
 
Anatomy and Structure of the MD 
The MD is considered to be the most developed in primates and its increase in 
size across species is comparable to that of the prefrontal cortex (Jones, 1998; Mitchell 
and Chakraborty, 2013). The primate MD contains four distinct divisions: the 
magnocellular (MDmc) division located antero-medially, the parvocellular (MDpc) 
division that is located centrally throughout the rostro-caudal extent, and the pars 
multiform (MDmf) and the densocellular (MDdc) divisions located laterally, rostrally and 
caudally, respectively (Bachevalier et al., 1997; Jones, 1998). Each division of the MD is 
reciprocally connected to specific regions in the PFC. The MD receives inputs from 
layers V and VI (Giguere and Goldman-Rakic, 1988; Yeterian and Pandya, 1994; Xiao et 
al., 2009). MD neurons that receive input from layer VI project back to layer IV, while the 
neurons that receive inputs from layer V project to layer III (Jones, 1998; Xiao et al., 
2009). Layer V pyramidal inputs are thought to recruit higher order thalamic nuclei, like 
the MD, which then influence cortico-cortical communication and cognition (Sherman 




MD divisions send and receive projections to distinct PFC regions. The MDmc is 
reciprocally connected to the orbitofrontal cortex and the ventromedial PFC and receives 
inputs from the ventrolateral PFC and dorsal anterior cingulate cortex (Preuss and 
Goldman-Rakic, 1987; Russchen et al., 1987; Barbas et al., 1991; Bachevalier et al., 
1997; Haber and McFarland, 2001; McFarland and Haber, 2002). The MDpc is 
reciprocally connected to the dorsolateral PFC and area 10 and receives inputs from the 
orbitofrontal cortex, ventrolateral PFC, and the dorsal anterior cingulate cortex (Preuss 
and Goldman-Rakic, 1987; Russchen et al., 1987; Barbas et al., 1991; Bachevalier et 
al., 1997; Haber and McFarland, 2001; McFarland and Haber, 2002; Erickson and 
Lewis, 2004). MDdc and the MDmf project diffusely to the PFC, dorsal anterior cingulate 
cortex, the frontal eye fields, and the basal ganglia (Preuss and Goldman-Rakic, 1987; 
Russchen et al., 1987; Barbas et al., 1991; Bachevalier et al., 1997; Haber and 
McFarland, 2001; McFarland and Haber, 2002; Erickson and Lewis, 2004; Erickson et 
al., 2004). 
The MDpc, which is reciprocally connected to the dorsolateral PFC, also receives 
input from the basal ganglia, specifically from the globus pallidus interna (GPi) and the 
substantia nigra reticulata (SNr) (Haber and McFarland, 2001; Haber and Calzavara, 
2009). These structures are associated with the direct pathway in the basal ganglia, the 
activation of which is associated with the production of movement. Inputs from the basal 
ganglia suggest that the MD plays a role in relaying motor information to prefrontal 
cortex (Alexander et al., 1986; Haber and McFarland, 2001; Yin and Knowlton, 2006; 






Lesions of the mediodorsal nucleus of the thalamus  
In humans, lesions restricted to the MD produce deficits on classical measures of 
prefrontal cognitive function including the WCST and Stroop task (Van der Werf et al., 
2000; Van der Werf et al., 2003). A finer grained analysis of MD lesions provided 
evidence that lesions restricted to the lateral portion (the MDpc) which projects to the 
dorsolateral PFC, produce stronger deficits in working memory than lesions of the 
medial portion (Zoppelt et al., 2003). Still, these experiments are sparse and 
inconclusive as to the full scope of executive function deficits following MD lesions, or 
the extent to which cognitive deficits derive solely from damage to MD, as infarcts 
restricted to MD are rare in human patients.  
 In rats, MD lesions produce deficits in spatial working memory (Harrison and 
Mair, 1996; Hunt and Aggleton, 1998a, b; Floresco et al., 1999; Mitchell and Dalrymple-
Alford, 2005; Block et al., 2007; Ouhaz et al., 2015). In non-human primates, MD lesions 
produce deficits in a variety of long term and working memory tasks, including deficits in 
recognition memory, novel object in place discrimination, object reward association, 
spatial delayed alternation and spatial delayed response (Isseroff et al., 1982; Aggleton 
and Mishkin, 1983a, b; Zola-Morgan and Squire, 1985; Gaffan and Murray, 1990; Gaffan 
and Watkins, 1991; Parker et al., 1997; Mitchell et al., 2007a; Mitchell et al., 2007b; 
Mitchell and Gaffan, 2008). Even though many of the behavioral effects of MD lesions 
also occur following PFC lesions, the level of deficit is attenuated following MD lesions 
compared to PFC lesions (Fuster, 2008; Chudasama, 2011). This suggests that MD 





Neurophysiology of the primate MD and MD-PFC network in relation to PFC cognitive 
functions 
Neurophysiological exploration of the MD has repeatedly found neurons that 
encode information about items stored in working memory during the delay period of 
delayed response tasks, similar to their PFC counterparts. The first reports of MD 
neurons exhibiting task selective activity during the delay period was provided by Fuster 
and Alexander (Fuster and Alexander, 1971, 1973). In these experiments, the authors 
recorded from MD neurons while monkeys performed a delayed response task and 
found that a majority of the recorded neurons exhibited significant delay period activity. 
Cooling the PFC diminished delay period activity in the MD, indicating that PFC input 
was necessary for the expression of delay period activity in MD neurons (Alexander and 
Fuster, 1973). Since these initial experiments, spatially-selective delay period activity in 
MD neurons has been reported during the performance of the oculomotor delayed 
response task (ODR) in which monkeys direct saccades to the locations of remembered 
visual targets (Tanibuchi and Goldman-Rakic, 2003; Funahashi et al., 2004; Watanabe 
and Funahashi, 2004a, 2018). Significantly more MD than PFC neurons encoded the 
direction of the saccadic response in the ODR task during the response period 
(Funahashi et al., 2004; Watanabe and Funahashi, 2004a). Also, in a version of the 
ODR task requiring that monkeys make a saccade in a direction rotated relative to the 
visual target (R-ODR), the neuronal population vector (vector sum of preferred directions 
of active neurons weighted by their firing rate) computed from MD neural activity rotated 
before the population vector in PFC (Watanabe et al., 2009). By comparing the activity of 
neurons between the ODR and R-ODR tasks, it was possible to determine whether 




response. These authors found that delay neurons encoding the future saccade direction 
comprised a larger fraction of active neurons in MD than PFC (Watanabe and 
Funahashi, 2004a, 2018). Taken together, these data suggest that the MD may play a 
stronger role in selection and execution of the motor response in comparison to the PFC.  
In alignment with the idea that MD plays a direct role in PFC network 
computations related to response selection, Wurtz and colleagues have provided 
evidence that MD neurons relay saccadic corollary discharge signals from the superior 
colliculus (SC) to the frontal eye fields (FEF) (Sommer and Wurtz, 2004b, a). In this 
experiment, the authors utilized electrical stimulation to trace anatomical pathways 
linking the SC to the PFC through the MD. They identified single MD neurons that both 
received SC input (as indicated by orthodromic responses to SC stimulation) and also 
projected to the FEF (as indicated by antidromic responses to FEF stimulation). Then, 
while monkeys performed a delay-saccade task they characterized the information 
encoded by this subpopulation of MD relay neurons. They found that MD relay neurons 
most effectively conveyed signals from the SC to the FEF that occurred at the time of the 
saccadic response and reflected its direction. Additionally, when the authors inactivated 
the MD using muscimol (a GABA agonist), the monkeys could still perform saccades to 
visual targets accurately. However, when two saccades needed to be made to two visual 
targets flashed in series, the direction of the second saccade did not take the first 
saccade into account – that is, the second saccade was made in the direction originating 
from the initial fixation position to the second peripheral target. This reflects a failure to 
update the saccade plan by the shift in eye position produced by the first saccade. The 
observations that MD relay neurons primarily conveyed saccade related information and 




movements together support the theory that copies of saccade commands (‘corollary 
discharge’) are conveyed from the SC to the FEF through the MD. This is one of the 
most well worked out frameworks for the functional significance of MD-PFC interactions, 
and the results are consistent with a strong role in response processing in this 
thalamocortical network. 
MD neurons also participate in nonspatial working memory. Tanibuchi and 
colleagues recorded MD neural activity during the performance of a delayed color 
match-to-sample, go/no go task (Tanibuchi et al., 2009b, a). They presented a stimulus 
(S1), either red or green, followed by a delay and second stimulus (S2), either red or 
green. The response was determined by the combination of the two stimuli: If S1 and S2 
were the same color, the monkey lifted a lever (‘Go’ response), if they were different 
colors, the monkey did nothing (‘NoGo’). The authors utilized electrical stimulation to 
identify MD neurons that received input from the SNr (substantia nigra reticulata) and 
that also projected to the principal sulcus. They report that activity in MD relay neurons 
encoded the color of S1 during the delay, as well as the color of S2 and the Go/NoGo 
response during the response period.  
 
Neurophysiology of the rodent MD-PFC network in cognitive control 
A number of studies have investigated the MD-mPFC network during task 
performance in rodents. Bolkan and colleagues (Bolkan et al., 2017) explored 
thalamocortical reciprocal interactions while mice performed a T-maze delayed 
nonmatch to sample task. Optogenetic inhibition of mPFC-to-MD and MD-to-mPFC 
pathways during the delay period impaired behavioral performance, suggesting a role for 




period inactivation of MD inputs to the mPFC had a stronger effect on behavioral 
performance than delay period inactivation of the mPFC inputs to the MD. Further, delay 
period inactivation of the MD-to-mPFC pathway weakened delay-period neural activity in 
the PFC and increasing activation in the MD-to-mPFC pathway during the delay 
improved working memory performance. In the choice phase, mPFC-to-MD interaction 
predominated. Specifically, optogenetic inhibition of the mPFC-to-MD pathway during 
the choice phase impaired performance, but inhibition of the reciprocal pathway did not. 
This suggested that communication between MD and PFC differed between the delay 
and choice phases of the task. Consistent with this, these authors also reported that the 
phase relationship between spikes in mPFC and beta oscillations in MD shifted between 
these periods, with mPFC spikes lagging MD beta oscillations in the delay period 
(suggesting MD-to-mPFC drive) and mPFC spikes leading MD beta oscillations in the 
choice period (suggesting mPFC-to-MD drive). Taken together, this data suggests that 
working memory maintenance of information relies on MD-PFC reciprocal interactions, 
with MD to the mPFC drive being particularly important, and further that response 
selection relies on mPFC input to the MD. Parnaudeau and colleagues (Parnaudeau et 
al., 2013) also examined the role of the MD in spatial working memory. They reported 
that pharmacogenetic inhibition of the MD resulted in the emergence of a behavioral 
impairment during the performance of the DNMS T-maze task and that MD neural 
activity phase locking to mPFC local field potentials (LFPs) in the beta frequency was 
strengthened during the choice phase and was preferentially affected when MD was 
inhibited (leaving phase-locking intact at theta and gamma frequencies). Lastly, Schmitt 
and colleagues (Schmitt et al., 2017) found that optogenetic inactivation of the MD 




resembled behavioral deficits following PFC optogenetic inactivation. MD inhibition 
resulted in diminished rule maintenance in PFC neurons during the delay period and 
PFC suppression resulted in the elimination of MD nonselective delay period activity. 
Studies of the rodent MD and mPFC network support the reciprocal dependency 
between the two areas for accurate and sustained maintenance of information during 
delay and choice periods.  
 
Taken together, these anatomical, lesion, and neurophysiological experiments 
demonstrate that the MD is crucial for PFC-dependent cognitive function. The 
involvement of the MD in relation to spatial working memory has been the focus of many 
of the described lesion and neurophysiological studies; however, it is still relatively 
unknown how the MD participates in cognitive control behaviors at a cellular level and 
how MD-PFC network dysfunction relates to cognitive deficits in patients with SZ. 
 
Cognitive deficits in Schizophrenia associated with MD-PFC network dysfunction 
Even though cognitive deficits are not part the diagnostic criteria for SZ, it is well 
documented that patients exhibit a wide-range of cognitive deficits. These include 
impairments in attention, working memory, processing speed, executive functioning, 
verbal fluency, verbal memory, and learning  (Nuechterlein and Dawson, 1984; Hoff et 
al., 1992; Saykin et al., 1994; Censits et al., 1997; Mohamed et al., 1999; Riley et al., 
2000; Townsend et al., 2001; Kerns et al., 2008; Kravariti et al., 2009; McCleery et al., 
2014). Executive function deficits consist of impairments on strategy formation and 
initiation, inhibition of prepotent responses and cognitive set shifting (Abramczyk et al., 




Patients exhibit these deficits often years before the onset and diagnosis of the illness as 
measured in clinically high risk populations (Jones et al., 1994; Cannon et al., 2000; 
Niendam et al., 2003; Wood et al., 2003; Hawkins et al., 2004; Bartók et al., 2005; Keefe 
et al., 2006; Lencz et al., 2006; Niendam et al., 2006; Pukrop et al., 2006; Smith et al., 
2006; Eastvold et al., 2007; Niendam et al., 2007; Pukrop et al., 2007; Simon et al., 
2007; Lesh et al., 2011), are stable over time (Jones et al., 2010; Albus et al., 2019), 
occur regardless of medication used (MacDonald et al., 2005b; Jones et al., 2010), and 
are predictive of functional outcome for patients (Green et al., 2004; Green, 2006; 
Ventura et al., 2009). Interestingly, first degree relatives of patients exhibit cognitive 
deficits, although milder in their expression (Franke et al., 1993; Keefe et al., 1994; 
Faraone et al., 1995; Egan et al., 2001; MacDonald et al., 2003; Kuha et al., 2007). 
Although cognitive deficits are pervasive across many patients with SZ, they are not 
reliably improved by either typical or atypical neuroleptics (Mortimer, 1997; Stip et al., 
2005).  
A key aspect of cognitive deficits in patients is the inability to use contextual 
information maintained across a delay to flexibly modify responses to subsequent stimuli 
(Barch et al., 2003; MacDonald, 2008; Lesh et al., 2011; Barch and Ceaser, 2012). 
Context processing combines many of the deficits described above into one construct 
(i.e. working memory, selective attention, response inhibition, executive control) (Cohen 
and Servan-Schreiber, 1992; MacDonald, 2008). This construct of context processing 
has provided a particularly selective measure of cognitive dysfunction in patients with SZ 
as deficits are found in patients regardless of medication state (Servan-Schreiber et al., 
1996) and in first-degree relatives (MacDonald et al., 2003; Richard et al., 2013). 




deficits but also to response inhibition and executive control, as deficits in context 
processing are correlated with deficits in the Stroop task (Cohen et al., 1999; 
MacDonald, 2008) and patients exhibit deficits in context processing even when the 
delay is removed from the task (MacDonald et al., 2003). Context processing deficits 
have been reliably measured in patients with SZ during the performance of the AX-
continuous performance task (AX-CPT) (Barch et al., 2003; MacDonald, 2008). 
Additionally, performance on the AX-CPT appears to reveal more severe and chronic 
impairments in patients with SZ spectrum disorders compared to patients with non-SZ 
psychosis, bipolar disorder, or depression (Barch et al., 2003; Barch et al., 2004; Holmes 
et al., 2005; MacDonald et al., 2005b; Brambilla et al., 2007). In addition to the AX-CPT, 
a variant of it, the dot-pattern expectancy (DPX) task, has also been used as a measure 
of context processing deficits in patients with SZ (MacDonald et al., 2005a; Jones et al., 
2010; Strauss et al., 2014; Lopez-Garcia et al., 2016; Ray et al., 2017; Chun et al., 2018; 
Smucny et al., 2019). The AX-CPT and DPX task have also been reported to engage the 
same neural network including the dorsolateral PFC and dorsal posterior regions, 
indicating similar recruitment of neural system independent of the stimuli used (Lopez-
Garcia et al., 2016). Due to the removal of familiar stimuli (letters) and replacement with 
unfamiliar stimuli (dot-patterns), the DPX task has been used in a pharmacological 
monkey model of SZ for translational purposes (Blackman et al., 2013).  
Functional neuroimaging and EEG studies have compared physiological 
activation of PFC and its distributed network in patients with SZ and control subjects to 
determine the mechanism cognitive control deficits that patients exhibit. PFC activation 
is consistently reduced in patients with SZ performing cognitive control tasks, including 




Weinberger et al., 1986; Weinberger et al., 1992; Seidman et al., 1994; Barch et al., 
2001; Perlstein et al., 2003; Yoon et al., 2008; Lesh et al., 2013; Poppe et al., 2016) and 
has been reported in SZ patients at first episode that are not on antipsychotic medication 
(MacDonald et al., 2005b). Additionally, disconnection across PFC networks has been 
found to be associated with cognitive control deficits. A recent functional imaging study 
investigated patterns of functional coupling between areas in PFC cortical networks 
during DPX task performance and found significant reductions in network connections in 
patients with SZ (Ray et al., 2017), a pattern that has been observed in multiple task 
contexts (Fornito et al., 2012). 
Additional evidence indicates that reduced functional activation specifically of the 
MD-PFC network is associated with cognitive control impairments in patients with SZ. A 
meta-analysis of 41 imaging studies in patients with SZ during performing cognitive 
control tasks identified which activation differences between patients and control 
subjects were most commonly associated with poorer cognitive performance in the 
patient group (Minzenberg et al., 2009). Studies using many different cognitive tasks 
were selected to probe effects across different cognitive domains, including DMS, N-
back, AX-CPT and Stroop tasks. They report reduced activation in the left dorsolateral 
PFC, rostral/dorsal ACC, and left MD correlated with poorer cognitive control 
performance in patients and that these regional reductions were significantly correlated 
across individuals. A recent study determined that a reduction in anatomical connectivity 
using DTI between MD and PFC correlated with poorer working memory performance on 
delayed response tasks but did not correlate with poorer performance on the AX-CPT 




cognitive behaviors following cognitive behavioral therapy correlated with functional 
thalamocortical coupling (Ramsay et al., 2017).  
In order to better characterize the potential dysfunction in MD-PFC network in 
SZ, imaging studies have explored thalamocortical functional connectivity at rest. 
Resting state functional connectivity using MRI has shown that MD-PFC connectivity is 
reduced in SZ (Welsh et al., 2010; Woodward et al., 2012; Anticevic et al., 2014b; 
Anticevic et al., 2014a; Tu et al., 2015). This reduction was unique to MD-PFC 
thalamocortical connections, as functional connectivity between motor and 
somatosensory cortices and the thalamus were increased in SZ (Woodward et al., 2012; 
Anticevic et al., 2014a). Moreover, MD-PFC functional disconnection has been 
demonstrated in patients at both early-stage and chronic stages of illness (Woodward 
and Heckers, 2016), as well as in clinically high-risk individuals before the onset of SZ 
symptoms (Anticevic et al., 2015b). This suggests that the thalamocortical disconnection 
between the MD and PFC occurs, potentially, prior to onset and persists throughout the 
course of the disorder. Taken together, these studies support functional disconnection 
between the MD and PFC in patients with SZ that may result in PFC-network failures 
underlying cognitive deficits. 
 
NMDA receptor hypofunction and the disconnection theory of Schizophrenia 
Glutamatergic signaling, particularly via NMDARs, has been implicated via 
genetic, molecular, and pharmacological studies as altered in SZ (Stone et al., 2007). 
Post-mortem assays have reported decreased cortical expression of NMDAR mRNA in 
prefrontal cortex (Sokolov, 1998) and temporal cortex (Humphries et al., 1996), as well 




transmission, including PSD95 (Funk et al., 2009). Additionally, genome-wide 
association studies have identified a family of single nucleotide polymorphisms (SNPs) 
that increase risk of SZ and that are located near genes coding for proteins that 
influence NMDAR dependent synaptic transmission (Schizophrenia Working Group of 
the Psychiatric Genomics Consortium, 2014). Pharmacological studies have reported 
that NMDAR antagonists, like phencyclidine (PCP), ketamine, and dizocilpine (MK-801) 
can reliably reproduce positive, negative and cognitive symptoms of SZ (Luby et al., 
1959; Krystal et al., 1994; Javitt, 2007; Anticevic et al., 2015a; Xu et al., 2015; Cheng et 
al., 2018). Recently, pharmacological treatments targeted at NMDAR modulation via 
glycine or d-serine have found improvement in positive and negative symptoms (Tsai 
and Lin, 2010; Umbricht et al., 2014). However, these effects have been hard to 
replicate reliably (Weiser et al., 2012; Goff, 2014).  
A dominant theory of schizophrenia proposes that disconnection of prefrontal 
networks underlies the essential dysfunctions in neural activity and cognition in patients 
(Friston, 1998; Stephan et al., 2006). Post-mortem studies in SZ reveal a loss of 
dendritic spines on pyramidal neurons, particularly in layer 3 of dorsolateral PFC cortex 
(Glantz and Lewis, 1997, 2000; Kolluri et al., 2005; Glausier and Lewis, 2013). NMDARs 
are involved in spike timing dependent plasticity (Dan and Poo, 2004; Stephan et al., 
2006; Feldman, 2012), and deficits in NMDAR function could contribute to activity-
dependent disconnection of PFC local and thalamocortical circuits. It was recently 
reported that repeated exposure to phencyclidine (PCP, an NMDAR antagonist) in 
monkeys resulted in a reduction in synchronous (‘0-lag’) spiking in prefrontal neurons 
along with the chronic disconnection of local PFC circuits (Zick et al., 2018). Therefore, 




thalamocortical networks both by disturbing the molecular mechanisms of synaptic 
plasticity as well as the synchronicity of spiking activity that enhances synaptic 
connectivity via spike-timing dependent plasticity. It has been hypothesized that loss of 
thalamic glutamatergic input to layer three of dorsolateral prefrontal cortex may 
contribute to the reduction in dendritic spines that is found there (Kolluri et al., 2005; 
Lewis and González-Burgos, 2008; Glausier and Lewis, 2013). Finally, thalamic volume 
has also been found to be altered, particularly in higher order thalamic nuclei like the 
MD, in SZ (Smith et al., 2011). Together, this data points to the potential for 
thalamocortical disconnection to underly cognitive control deficits in SZ due to a 
decrease in PFC local and thalamocortical circuit function. However, we are still lacking 
an understanding of how cells in the MD and PFC contribute to cognitive control and 
how their dysfunction contributes to cognitive control deficits in SZ. 
 
Animal model of cognitive control deficits in SZ 
What is missing in our understanding of schizophrenia as a disease is how the 
function of neurons is altered at the cellular level to produce cognitive deficits and 
symptoms. To answer these questions requires animal models that allows us to reliably 
and validly translate cognitive deficits from patients to animal models and back-translate 
neural deficits (and eventually treatments) from animal models to patients (Averbeck and 
Chafee, 2016; Mitchell et al., 2018; Heilbronner and Chafee, 2019). Developing animal 
models of SZ is particularly challenging because many of the symptoms (including 
affective and perceptual changes that are expressed primarily through language) are 
difficult if not impossible to model in any nonhuman species. Another factor limiting the 




extent to which neural architecture and computations differ between species. There are 
two primary dimensions along which animal models and patients with SZ need to be 
matched: behavioral manifestations of SZ such as cognitive deficits, and causal factors 
that increase risk of SZ, specifically genetic mutations. A number of mouse genetic 
models have been developed to explore the effect of risk mutations on prefrontal 
network dynamics and cognitive functions (Kellendonk et al., 2009; Jones et al., 2011; 
O'Tuathaigh et al., 2013; Leung and Jia, 2016; Simpson and Kellendonk, 2017; Van et 
al., 2017). However, the extent to which mice can mimic either cognitive deficits or 
prefrontal network dynamics in humans is not clear. It is likely that nonhuman primates 
are superior in this regard because monkeys can more accurately mimic cognitive 
deficits in patients with SZ (Blackman et al., 2013), and the degree of anatomical 
homology between prefrontal networks in humans and monkeys is much greater than 
between humans and rodents (Preuss, 1995), particularly including PFC neural networks 
(Preuss, 1995; Uylings et al., 2003; Carlén, 2017). The approach we, as a lab, have 
taken is to use NMDAR blockade to induce a state of cognitive (Blackman et al., 2013) 
and prefrontal network (Zick et al., 2018) failure using NMDAR antagonists that is 
potentially analogous to cognitive and network failures occurring in SZ.  
It is important to consider the extent to which the NMDA receptor antagonist 
model exhibits face, construct, and predictive validity. The face validity of an animal 
model depends on the extent to which it can mimic outward manifestations of SZ, such 
as cognitive deficits that are seen in patients. The construct validity of an animal model 
relates to the extent to which the model replicates causal factors such as genetic 
mutation or underlying neural dysfunctions producing the SZ in humans. Lastly, the 




are effective in restoring function in the animal model accurately predict how humans 
with the disease will respond to the same intervention. In regards to face validity, NMDA 
receptor antagonists, such as phencyclidine (PCP) and ketamine, reproduce the full 
spectrum of behavioral manifestations of SZ, including positive, negative and cognitive 
symptoms in humans and animal models (Luby et al., 1959; Krystal et al., 1994; Jones 
et al., 2011; Frohlich and Van Horn, 2014; Anticevic et al., 2015a; Lodge and Mercier, 
2015; Xu et al., 2015; Cheng et al., 2018). Repeated administration of NMDA receptor 
antagonists acutely and chronically decreases prefrontal DA utilization and glutamate 
levels in the prefrontal cortex that are correlated with impairment performance on a 
delayed alternation T-maze task and ODR task (Jentsch et al., 1997b; Jentsch et al., 
1997a; Jentsch et al., 1998; Tsukada et al., 2005) and spine density in the PFC that are 
similar to findings in patients with schizophrenia (Kolluri et al., 2005; Hajszan et al., 
2006; Lewis and González-Burgos, 2008; Jones et al., 2011; Glausier and Lewis, 2013), 
supporting the construct validity of the NMDAR antagonist model. Evidence that NMDAR 
transmission is aberrant in patients with SZ provides additional support (Humphries et 
al., 1996; Sokolov, 1998; Stone et al., 2007). NMDA receptor antagonist models also 
have predictive validity due to data showing that atypical antipsychotics ameliorate the 
negative effects of NMDA receptor antagonists on spatial learning, spatial memory, and 
reversal learning (Abdul-Monim et al., 2006; Didriksen et al., 2007; Roberts et al., 2010; 
Jones et al., 2011).   
To further increase the translational strength of our pharmacological monkey 
model, we back-translated a task that effectively targets specific cognitive deficits in 
context processing, working memory, and prepotent inhibition in patients with SZ 




counterpart, the AX-Continuous performance task (AX-CPT), consist of four different trial 
types that require a response to a probe stimulus based on the previously shown cue 
stimulus. Patients with SZ exhibit a specific error in responding when a habitual 
response to the probe stimulus must be countermanded based on the prior cue stimulus’ 
identity, regardless of illness stage or medication (MacDonald et al., 2005b). Monkeys 
that perform the DPX task following an injection of PCP exhibit the same error pattern 
(Blackman et al., 2013). The experiments described in this dissertation investigate 
altered PFC thalamocortical function in the NMDAR antagonist monkey model, 
leveraging the face, construct, and predictive validity of this model to increase the 
probability that neural pathophysiology I find will be relevant to network failure in patients 
with SZ. 
 
Specific goals and significance of the current experiments  
The overarching goal of my thesis work is to characterize the role of PFC – MD 
network dynamics underlying the production cognitive control deficits in a monkey model 
of SZ. To this end, I first describe the role of the MD thalamus in cognitive control 
behavior as it relates to the PFC and characterize the distribution and transmission of 
information processing between the MD and the PFC. Then, I characterize how the MD-
PFC network is changed following exposure to the NMDA receptor antagonist, PCP. To 
accomplish this goal, I performed large-scale recording of neural activity within the MD 
and PFC, simultaneously, and related this spiking activity to cognitive control 
performance and the subsequent changes caused by NMDA receptor blockade. As will 
be seen below, the MD and PFC, while similar in regard to the encoding of cognitive 




differentially affected by PCP. I am the first to perform large-scale recordings in the MD 
and the PFC concurrently, during performance of a context processing task, and in a 
model of the cognitive deficits in schizophrenia. The findings described in my 
dissertation will further our understanding of higher-order thalamocortical networks 
underlying cognitive control and how those networks may be affected in SZ. Further, this 
research could inform the development of therapeutics that target thalamic structures to 























Thalamocortical dynamics in the healthy state: Relation of MD-PFC 
neural activity to computations for cognitive control 
 
ABSTRACT 
The MD thalamus has been implicated to play a role in a range of cognitive 
functions via reciprocal connections with the PFC (Watanabe and Funahashi, 2012; 
Mitchell and Chakraborty, 2013; Parnaudeau et al., 2018). Still, little is known about how 
the neurons in the primate MD directly participate in cognitive control. To address this 
question, I trained monkeys to perform a cognitive control task that reliably measures 
cognitive deficits in patients with schizophrenia, the dot pattern expectancy task 
(MacDonald et al., 2005a; Jones et al., 2010), and used linear multi-electrode arrays to 
record neural activity in the MD and PFC simultaneously. I found that the MD contained 
neurons, like their PFC counterparts, that encoded the cognitive control state (the need 
to override the habitual response) that did not reflect stimulus features and was not 
aligned to the motor response. Additionally, these state neurons modulated their activity 
based on the amount of cognitive control required. I report that response signals were 
markedly more common in the MD than the PFC, single neuron and population level 
representations of the response were much stronger in the MD compared to the PFC, 
and MD neurons did not exhibit a preference bias for the non-habitual response as did 
the PFC neurons. I also found that transmission of task-relevant information within and 




evidence that the MD is recruited for cognitive control processing via PFC input and the 
MD plays a stronger role in response selection. 
 
INTRODUCTION  
Cognitive control is the ability to use internally stored rules or goals to modify the 
mapping between sensory inputs and motor outputs; It is the flexible and purposeful 
resolution of action conflict. The prefrontal cortex (PFC) has been implicated as a key 
brain region involved in a number of aspects of cognitive control (Goldman-Rakic, 1987; 
Miller and Cohen, 2001; Schiffer et al., 2015). Neurophysiology studies have found that 
spiking activity in PFC neurons encodes the state of the task (Asaad et al., 2000), rules 
(Wallis et al., 2001b; Buschman et al., 2012), and abstract categories (Freedman et al., 
2001; Christoff et al., 2009; Goodwin et al., 2012; Crowe et al., 2013b), and they rapidly 
adapt to changes in rules and context by adjusting how stimulus features are mapped 
onto actions (Roy et al., 2010; Goodwin et al., 2012; Mante et al., 2013; Crowe et al., 
2014; Blackman et al., 2016). Challenging traditional thought of cognitive control as 
merely a cortical phenomenon, the mediodorsal nucleus of the thalamus (MD) has 
arisen as potential region involved in cognitive functions for its extensive reciprocal 
connections to the PFC (Goldman-Rakic and Porrino, 1985; Preuss and Goldman-Rakic, 
1987; Xiao et al., 2009) and its involvement in a number of aspects of cognition. MD 
lesions in the monkeys (Isseroff et al., 1982; Zola-Morgan and Squire, 1985; Parker et 
al., 1997) and inactivation of the MD in rodents (Parnaudeau et al., 2013; Bolkan et al., 
2017; Schmitt et al., 2017) produce deficits in working memory. Additionally, lesions in 
humans restricted to the MD produce executive function deficits as measured by the 




Neurophysiological experiments have found that during working memory based tasks, 
primate MD neurons encode the state of the task, exhibit delay period activity, and 
provide impending response information to the cortex (Fuster and Alexander, 1971, 
1973; Tanibuchi and Goldman-Rakic, 2003; Sommer and Wurtz, 2004b, a; Watanabe 
and Funahashi, 2004b, a; Tanibuchi et al., 2009b; Watanabe et al., 2009; Watanabe and 
Funahashi, 2018). Furthermore, the PFC and MD physiologically interact during working 
memory, as indicated by the finding that inactivation of prefrontal cortex attenuates 
working memory signals in the MD nucleus in primates (Alexander and Fuster, 1973). 
Rodent studies inactivating the MD have found a similar attenuation of working memory 
signals in the mPFC (Bolkan et al., 2017; Schmitt et al., 2017). Still, simultaneous MD-
PFC recording has not been conducted in monkeys performing a cognitive control-based 
task, to our knowledge, leaving a gap in our understanding of the role of the MD neurons 
in cognitive control performance and how neurons in both regions interact during said 
performance.  
Patients with schizophrenia exhibit deficits in cognitive control that are reliably 
measured by the AX continuous performance (MacDonald et al., 2005b) and dot-pattern 
expectancy (DPX) tasks (MacDonald et al., 2005a; Jones et al., 2010), regardless of 
disease state or medication. Cognitive control deficits in patients have also been 
associated with reduced activation of the MD nucleus and the PFC (Minzenberg et al., 
2009). To relate cognitive control deficits to altered prefrontal network dynamics at the 
cellular level, my lab previously translated the DPX task to nonhuman primates 
(Blackman et al., 2013; Blackman et al., 2016; Zick et al., 2018). In order to determine 
how the MD-PFC network functions during performance of a cognitive control task, I 




goals of this experiment were to determine 1) how the MD represents cognitive control 
performance information and 2) the dynamics within and between the two structures 
underlying aspects of healthy state cognitive control behavior. I found that the MD 
contains neurons that reflect cognitive control in a similar manner to the PFC. However, 
the PFC produces strong counter-habitual signals specifically when cognitive load is 
high, while the MD produces signals relating to action selection based on changing 
contexts. I also report that MD and PFC neurons reciprocally transmit information about 
task variables to one another during different trial periods.  
 
MATERIALS AND METHODS 
 
Subjects 
I recorded neural activity in the dorsolateral PFC and the MD in two male 
monkeys (Macaca Mulatta; 8-11 kg) during performance of the DPX task. All animal care 
and experimental procedures conformed to the National Institutes of Health guideline 
and compiled with protocols approved by the Animal Care and Use committee at the 
University of Minnesota and the Minneapolis Veterans Affairs Medical Center.  
 
The DPX Task and Conditions 
The DPX task was described in detail in a previous report from my lab (Blackman 
et al., 2013). Monkeys sat in a primate chair about 77.5 cm in front of a back-projection 
screen. An LCD projector (Dell 5100MP DLP) presented the visual stimuli. An infrared 
eye tracking system (ISCAN Inc. Woborn, MA) recorded eye position at 60 Hz. Each trial 




joystick response (left or right) depending on cue-probe sequence shown. Cue and 
probe stimuli consisted of patterns of dots: A-cues and X-probes each consisted of a 
single dot pattern, while B-cues and Y-probes were any of 5 dot patterns each (Fig. 
2.1B). Trials began with a 500 ms period of gaze fixation of a central fixation target 
(cross). Gaze fixation within 3.3° of a fixation cross was required until the response was 
made. After the initial fixation period, a cue stimulus was presented at the center of the 
display for 1.0 s. Following the presentation of the cue there is a 1.0 s delay period that 
contained only the fixation cross. Next a probe stimulus was displayed for 0.5 s at the 
center of the display. The cue and probe stimuli subtended 2.7° - 4.4° of visual angle. 
From the time the probe stimulus was presented, the monkey had 1.0 s to move a 
handheld joystick to the left or right. A correct, target or nontarget response movement, 
determined by the combination of the presented cue and probe stimuli, was rewarded by 
a delivery of a drop of juice (~0.1ml) at the end of the intertrial interval (1.1 s after probe 
offset). Trials in which an A-cue was followed by an X-probe (AX trials) were valid trials, 
requiring a leftward joystick movement (target response). All other cue-probe 
combinations (AY, BX, and BY) were invalid trials that required a rightward joystick 
movement (nontarget response; Fig. 2.1C). The probe was presented for the entirety of 
the 0.5 s probe period, regardless of the time of the response (analogous to the way the 
task is administered for human subjects).  
We administered the DPX task in two different trial sets, balanced and prepotent, 
which differed in the proportion of cue and probe stimuli. In balanced sets there were an 
equal proportion of the four cue-probe trial sequences (AX, AY, BX, BY). These included 
80, 200, or 400 trials (in 20, 27, and 1 neural ensemble(s), respectively). In prepotent 




The remaining trials (31%) presented nontarget cue-probe sequences (AY 12.5%, BX 
12.5%, BY 6%). Prepotent trial proportions were replicated from the DPX task and AX-
CPT that were administered to patients (MacDonald et al., 2005a; Jones et al., 2010). 
Prepotent sets included either 320 or 400 trials total (in 19 and 29 ensembles, 
respectively). For neural ensembles included in this study, I recorded neural activity 
during the performance of both a balanced and prepotent trial set. The prepotent sets 
presumably create a prepotent motor habit to produce the leftward joystick movement in 
response to the X-probe presentation, as this was the required response ~4/5 of the 
times the X-probe was presented. Overriding this habitual response on BX trials 
therefore required utilization of cognitive control to countermand a prepotent action. AY 
trials similarly required increased cognitive control, as the A-cue implies the target 
response, which the Y-probe must countermand. 
Monkeys received an intramuscular injection of saline (Mk1: 0.3mL; Mk2: 0.6mL) 
before recording neurophysiological data for 18 of the 48 neural ensembles included in 
this study. These saline injections were part of a study to investigate the effects of the 
NMDA receptor antagonist phencyclidine on the neural activity in the mediodorsal 
nucleus of the thalamus and the prefrontal cortex. All neural data included in the present 
study were recorded before monkeys had been exposed to phencyclidine.  
 
Neural Recording 
Prior to surgery structural MRI images of monkeys were obtained at 3T to 
localize target recording regions: the banks of the principal sulcus in prefrontal cortex 
(PFC, Brodmann area 46) and the mediodorsal nucleus of the thalamus (MD) (Fig. 2.2). 




cortical surface reconstructions of the locations of cortical sulci obtained from MRI 
images (Fig. 2.2A, B). In order to visualize electrode trajectories in depth and target the 
MD, I used the Cicerone software package (Miocinovic et al., 2007) that generated 3D 
rotatable MRI volumes from the 2D image stack and visualized chamber placements and 
electrode angles. This allowed for more precise chamber placement to achieve specific 
electrode angles that intersected the MD in each monkey. Following recording, I 
obtained CT scans to visualize recording locations. I inserted stainless steel probes of 
approximately the same diameter as the recording electrodes passing through the center 
of locations and depths where MD neural recordings were conducted. The steel probe 
was visible in the CT scans. I uploaded the CT image stack into Cicerone and aligned 
the CT and pre-recording MR image stacks. I confirmed the trajectory of the electrode 
penetrations that intersected the MD in both monkeys (Fig. 2.2C, D; eliminating data 
from 2 days of recording in which the electrode missed MD).  
Monkeys underwent an aseptic surgical procedure under isoflurane gas 
anesthesia (1-2%). Two craniotomies were made in the skull, one positioned to record 
from the dorsolateral PFC and one positioned to record from the MD in the left cerebral 
hemisphere. Five titanium posts were screwed to the surface of the skill using titanium 
screws. PEEK recording chambers (PFC: 19mm i.d.; MD: 16mm i.d.) were placed over 
the craniotomies and fixed to the screws and posts using surgical bone cement. A halo 
was attached to the posts using metal tabs for head stabilization. Post-surgical analgesia 
was maintained for several days using an injectable analgesic (Buprenex, 0.05mg/kg 
i.m., twice a day).  
Neurophysiological recordings were obtained using dual 32-channel silicone 




Arbor, MI) each advanced independently into the brain using a NAN motorized 
Microdrive (NAN Instruments; NAN C Drives; Nazareth Illit, Israel). Two vector array 
electrode geometries were used throughout the experiment (‘Edge’, 32 electrodes in a 
linear array, 100 µm spacing; and ‘Poly2’, 2 staggered 16 electrode linear arrays, 50 µm 
spacing), extending from the end of a 400 µm O.D. stainless tube support body. I 
advanced each electrode through a stainless-steel guide tube (600 µm O.D.) which 
penetrated the dura. The edge design was used for MD recording in 29 ensembles and 
the poly2 design was used in the remaining 19 ensembles. The poly2 design was used 
for all 48 ensembles in the PFC. Neural data was recorded via a 64-channel Ephys 
digital signal processing data acquisition system (Tucker-Davis Technologies Inc., 
Alachua, FL). Recorded signals on each electrode were amplified and bandpass filtered 
(between 100 and 5000 Hz) and monitored during neural recording for the emergence of 
spiking neural activity once electrodes passed from white matter into the MD nucleus 
and to evaluate stability of spiking activity during recording. Amplified and filtered 
electrode signals were sampled at a frequency of 24414.1 Hz and saved to disk along 
with time stamps indicating behavioral events. I sorted the action potentials of individual 
neurons based on a principle components analysis of recorded signals implemented by 





I analyzed differences in percent correct performances as a function of trial type 




correct and error trials per trial type (p<0.05). I analyzed differences in response time as 
a function of trial type using a Kruskal-Wallis test followed by post-hoc pairwise Tukey-
Kramer tests. 
 
ANCOVA - based classification of neural activity 
 I applied analysis of covariance (ANCOVA) to trial-wise firing rates measured 
within cue, delay, probe and response windows to detect significant modulation in 
relation to task variables. Cue, delay and probe windows were coextensive with their 
corresponding task epochs (Fig. 2.1). The response window was ± 200 ms centered on 
the time of the joystick movement. I used firing rates in the pre-cue fixation period as the 
covariate to control for trial-by-trial fluctuations in baseline activity. I applied ANCOVA to 
firing rates for all neurons combined across prepotent and balanced trial sets. To identify 
neurons in which activity varied as a function of the cue stimulus during the cue or delay 
periods I applied a one-way ANCOVA with cue (A vs B-cue) as the single factor to firing 
rates in these time periods. To identify neurons in which activity varied as a function of 
the cue and probe stimulus during the probe period, I applied a two-way ANCOVA with 
the cue stimulus (A vs. B) and the probe stimulus (X vs. Y) as the factors. To identify 
neurons in which activity varied as a function of the response, I applied a one-way 
ANCOVA with response direction (target vs. nontarget) as the single factor. Neurons 
were classified on the basis of the trial periods and the task factors yielding significance 
in the ANCOVAs (p<0.05) and based on the preference for one of the stimuli (A vs B or 
X vs Y) or response (target vs nontarget) factors. I further split cue neurons in to 
separate classifications based on the time in the trial that their neural activity was 




those with a cue preference during the cue period, delay cue neurons were those with a 
cue preference during the delay period, and late cue neurons were those with a cue 
preference during the probe period.  
To compare significant differences in MD and PFC population proportions of 
significant neurons assigned to the ANCOVA-defined categories, I performed Z-score 
tests of proportions across the categories in the MD and PFC (i.e. proportion of all 
significant neurons in the MD vs proportion of all significant neurons in the PFC, 
proportion of significant cue neurons in the MD vs proportion of those in the PFC, 
proportion of significant probe neurons in the MD vs. proportion of those in the PFC, and 
proportion of response neurons in the MD vs proportion of response neurons in the 
PFC). I also wanted to determine significant biases with ANCOVA -defined categories 
existed within the MD and the PFC. To do this I performed a one sample Z of 
proportions within each category (early A vs B cue, delay A vs B cue, late A vs B cue, 
probe X vs Y, and response target vs nontarget; p<0.05, two-tailed).  
 
Analysis of population of average activity 
To obtain continuous estimations of firing rate (spike density functions, SDFs), I 
convolved each neuron’s spike train with a Gaussian kernel (with a SD of 40 ms) using 
the ‘ksdensity’ function in Matlab. I averaged single trial SDFs over groups of trials with 
the same cue-probe sequence (AX, AY, BX, BY) for each neuron and then averaged 
SDFs over neurons with the same cue, probe or response preference to visual 
population activity (Fig. 2.5).  
I found that individual neurons often exhibited different stimulus preferences at 




variables in the ANCOVA making it difficult to classify neurons using traditional 
ANCOVA-based methods. I compared activity patterns across ANCOVA defined 
categories and identified patterns of significant ANCOVA results that corresponded to 
the same functional groups of neurons. This resulted in seven neuronal groups based on 
unique combinations task periods (cue, delay, probe, response) and factors (cue, probe, 
response), combined with the specific stimulus or response preferences of each neuron 
during those periods (Fig. 2.6). The groups are non-overlapping and take into account all 
of the functional preferences I observed. Group 1 neurons (‘Early A-cue’) were 
significant for the A-cue during the cue period. Group 2 neurons were significant for the 
B-cue during the cue period or the Y-probe during the probe period (‘Early B-cue or Y-
probe’; that is, neurons with either significant result exhibited essentially the same 
activity profile and so were combined). Group 3 neurons were significant for the A-cue 
during the delay or probe periods (‘Delay A-cue or Late A-cue’). Group 4 neurons were 
similarly defined as Group 3 neurons were but preferred the B-cue (‘Delay B-cue or Late 
B-cue’). Group 5 neurons were significant for the X-probe during the probe period. 
Groups 6 and 7 were significant for the response factor during the response period and 
preferred target (Group 6) and nontarget (Group 7) responses respectively. If a neuron 
was significantly modulated based on multiple task factors as indicated by the pattern 
results of the ANCOVA above, assignment to one group was determined by the factor 
associated with the most significant p-value. This grouping scheme is a modification of 
one developed previously in my lab to describe the heterogeneity of neural responses in 
PFC (Blackman et al., 2016), modified to accommodate new patterns of activity I 





Cue preference Index 
To further understand the nature of cue preference switching between B-cues 
early in the trial and A-cues late in the trial, I computed a cue preference index to 
quantify the cue preference of each neuron for A and B cues, during the cue or probe 
period, as follows: 
𝐼𝑛𝑑𝑒𝑥𝑐𝑢𝑒 =
(𝐴𝑐𝑢𝑒  − 𝐵𝑐𝑢𝑒)
(𝐴𝑐𝑢𝑒  + 𝐵𝑐𝑢𝑒) 
 
𝐼𝑛𝑑𝑒𝑥𝑝𝑟𝑜𝑏𝑒 =
(𝐴𝑝𝑟𝑜𝑏𝑒  − 𝐵𝑝𝑟𝑜𝑏𝑒)
(𝐴𝑝𝑟𝑜𝑏𝑒  +  𝐵𝑝𝑟𝑜𝑏𝑒) 
 
A is the average firing rate of a given neuron during A-cue trials and B is the average 
firing rate of the same neuron during B-cue trials. Cue subscript indicates firing rates 
were taken from the cue period and probe subscript indicates firing rates were taken 
from the probe period. Then to capture the switch in cue preference, I computed the 
difference cue preference indices between the cue and probe period: 
𝐼𝑛𝑑𝑒𝑥𝑠𝑤𝑖𝑡𝑐ℎ = 𝐼𝑛𝑑𝑒𝑥𝑝𝑟𝑜𝑏𝑒 −  𝐼𝑛𝑑𝑒𝑥𝑐𝑢𝑒 
Lastly, I performed a permutation test to evaluate the significance of switch index 
for each neuron by shuffling firing rates between the cue and probe period (1000 
iterations) and recalculating the switch index. I considered the original switch index for a 
given neuron significant if it was greater than the 97.5 percentile or less than the 2.5 
percentile of the shuffled distribution (p<0.05, two-tailed). To determine if the number of 
neurons that significantly switched their cue preference from B-cues in the cue period to 
A-cues in the probe period (cognitive control encoding neurons) were more or less 
numerous than neurons that switched their preference in the opposite direction (from A-
cue in the cue period to B-cue in the probe period), I calculated a Z-test of proportions 




on proportions of switch neurons in the MD and the PFC to determine if there were 
region-specific differences in the number of neurons that encoded cognitive control 
encoding.  
 
Analysis of cognitive control load on neural activity  
During the cue period, B-cues were associated with high cognitive control load 
(since they countermanded the habitual target response) and A-cues with low cognitive 
control load. The difference in firing rate between B and A-cue trials therefore provides a 
measure of cognitive control encoding. Similarly, during the probe period, AY trials were 
associated with high cognitive control load (since the Y-probe countermanded the 
habitual target response implied by the A-cue), and AX trials with low cognitive control 
load. To measure the influence of cognitive control on neural activity, I computed the 
difference in firing rate during the cue period on B-cue and A-cue trials, as well as the 
difference in firing rate during the probe period on AY and AX trials. I then compared 
these rate differences on a per neuron basis between balanced and prepotent trial sets 
and evaluated differences between them using a permutation test in which I shuffled 
trials of neural activity between the two sets and recomputed rate differences (100 
iterations). I considered the difference in cognitive control effects on neural activity 
between balanced and prepotent datasets significant if it exceeded the 95th percentile of 
the bootstrap distribution (p < 0.05). 
 
Sliding-window regression analysis  
 I applied a sliding-window regression analysis to evaluate the strength and 




of time within the trial. I measured firing rates of single neurons on correct trials of 
prepotent trial sets, separately, within a sliding 100 ms window (advanced in 20 ms 
steps), and at each time step regressed the trial-by-trial firing rates onto the cue, probe, 
and response by fitting the following linear models: 
𝑅 = 𝛽0 + 𝛽1𝐶𝑢𝑒 + 𝛽2𝑃𝑟𝑜𝑏𝑒 + 𝛽3𝐶𝑢𝑒 ∗ 𝑃𝑟𝑜𝑏𝑒 + 𝜀 
𝑅 = 𝛽0 + 𝛽1𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 + 𝜀 
R is firing rate, Cue (A vs B), Probe (X vs Y), and Response (target vs nontarget) were 
dummy coded categorical variables, and E is the error (residual).  
Neurons were ranked according to the magnitude of the peak significant 
regression coefficient and neuron numbers were equalized across brain areas by 
restricting the analysis to equal numbers of the most significant neurons in the two 
areas. The results of the regression analysis were then expressed as the proportion of 
explainable variance (PEV) associated with each regressor (Brincat and Miller, 2016), 
computed using the formula of (Olejnik and Algina, 2003): 
𝜔2 =
𝑆𝑆𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑔𝑟𝑜𝑢𝑝𝑠 − 𝑑𝑓 × 𝑀𝑆𝐸
𝑆𝑆𝑡𝑜𝑡𝑎𝑙 + 𝑀𝑆𝐸
 
To determine if there was a significant difference in the timing of signals across 
brain areas, I applied a Kolmogorov–Smirnov test to the cumulative distributions of the 
time to peak PEV. Additionally, I evaluated the significance of differences in population 
average PEV across the trial period between areas using a permutation test. I randomly 
shuffled regression results (PEV time series) between brain areas on a per neuron basis 
(1000 iterations) and compared the original difference between MD and PFC to the 




significant if they exceeded the 95th percentile of the bootstrap distribution and FDR 
corrected.  
 
Population decoding analysis  
To quantify information encoded by population activity patterns in the MD and 
PFC about the cue, probe, and response, I performed time-resolved pattern 
classification (Klecka, 1980; Johnson and Wichern, 1998; Crowe et al., 2010). I used the 
‘classify’ Matlab function with empirical prior probabilities derived from the frequency of 
trials with level of the decoded variable in the training data and the diagonal covariance 
matrix estimate (diaglinear) options. I measured the firing rates of all significant neurons 
or neurons in specific functional groups in a sequence of 50 ms time bins throughout the 
trial. At each 50 ms time step, I used population activity patterns to decode the cue, 
probe and response on individual trials by constructing a vector of firing rates 
representing the population activity pattern at that time point. To construct this vector, I 
matched trials over recording days according to the trial repetition number of each of the 
decoded task variables (the first A-cue trial for each neuron, for example) and included 
firing rates in 3 consecutive 50 ms time bins from each neuron comprising a 150 ms 
sliding window. I used leave-one-out cross validation to perform the decoding; All trials 
(except the trial being decoded) were used as the training set to compute the mean 
(centroid) and covariance matrix of population activity patterns for subsets of trials 
corresponding to the potential values of the decoded variable (A and B-cue when 
decoding cue, for example). I then computed the Euclidean distance between the 
population activity pattern on the decoded trial in a specific time bin and the two group 




group centroids defining the population codes for the decoded variable to change over 
time and always compared population activity patterns to group centroids computed 
using training data at the same time point. I then converted the distance between the 
population activity pattern and the group centroids to posterior probabilities of the trial 
belonging to each of the two groups under the assumption that the distribution of 
population activity patterns in each group was multivariate normal. I assigned the trial to 
the group with the higher posterior probability. Repeating the decoding over time bins 
produced a time series of posterior probabilities quantifying fluctuations in the strength of 
population signals encoding specific items of task-defined information. 
I included neurons in the populations if they had been recorded for a minimum 
number of trials in each set (70 trials for balanced and 230 trials for prepotent sets). I 
then ranked neurons in the two areas according to the significance of the p-value 
defining their group membership, and selected matching numbers of the most significant 
neurons in both the MD and the PFC. Equalizing neuron numbers and trial numbers 
removed differences between them as potential factors that would confound comparison 
between the strength of population encoding in the MD and the PFC. I used a 
permutation test repeating the decoding analysis after randomly shuffling trials of 
posterior probability time series between brain areas (1000 permutations). I considered 
original differences in decoding between brain areas significant if they exceeded the 95th 








Signal Transmission analysis 
 Signal transmission analysis functions under the assumption that temporal 
correlations in the information that two different patterns of activity encode about the task 
(such as cue identity) results from physiological interactions between those two groups 
of neurons. Correlations in temporal patterns of information can thus allow the 
identification of functional linkages between two groups of neurons that are recorded 
simultaneously. In order to determine whether functional linkages exists within and 
between the MD and PFC, I applied signal transmission analysis to sets of 
simultaneously recorded neurons (neural ensembles) (Crowe et al., 2013b) that encoded 
the cue, probe and response. This allowed me to capture physiological interactions 
between neurons encoding different task variables that may implement conditional 
computations required by the task (such as, if A-cue, and X-probe, then target 
response). First, I identified subsets of neurons within each ensemble that encoded task 
variables of interest (as determined by ANCOVA-based classification above). Next, I 
applied time-resolved pattern classification to decode task variables using activity 
patterns in the neural subsets. This is analogous to the population decoding above 
except that neurons were limited to the sets of neurons in the PFC and MD that were 
recorded simultaneously. The decoding produced two posterior probability time series 
that capture moment-to-moment fluctuation in the strength of neural signals encoding 
different task variables in different brain structures. The question I addressed is whether 
these fluctuations were correlated in time, and if so at what lag, to infer the direction of 
flow of information through networks. To obtain unbiased estimates of correlation 
between the two time series, I first removed linear trends and autocorrelation in the time 




probability time series. ARIMA models capture the variation in each time series 
explainable by its own prior history. The first step is to difference the time series to 
remove time trends. Next a regression is performed to predict the value at each time 
step as a weighted sum of prior values. Finally, additional regression coefficients are 
obtained to improve the prediction of the value at each time step by including a weighted 
sum of prior errors in prediction. I employed ARIMA models of order [10,2,2], including 
regressors for the 10 prior values in the time series in the autoregressive model, fitted 
the model after differencing the times series twice, and included regressors for the errors 
in estimation obtained for the prior 2 values. At this point, the residuals do not contain 
any variation based on its own history and are therefore likely to capture variation based 
on an outside source. I then used the residual values after fitting the ARIMA model to 
evaluate correlation between time series. I regressed one residual posterior probability 
time series onto the other within a sliding window of 500ms advanced in 50 ms time 
steps (at a lag of either plus or minus one 50 ms time bin). This produced a time series 
of F-statistics that measured fluctuation in the strength of functional coupling between 
groups of neurons that encoded task variables of interest in the same area or in different 
brain areas. When evaluating information transmission within area, the two groups of 
neurons were exclusive, eliminating the chance of the same neuron contributing to both 
times series in the final regression step. The significance of signal transmission was 
evaluated by comparing the transmission time series to a bootstrap distribution of time 
series obtained after randomly shuffling post-ARIMA probability time series between 
neural groups and repeating the sliding window regression analysis. I considered 
transmission significant if it exceeded the 95th percentile of the bootstrap distribution, 






Behavioral Performance  
The DPX task consists of four trial types based on four possible combinations of 
the cue (A, B) and probe (X, Y) stimuli (AX, AY, BX, BY; Fig. 2.1A-C) in sequence. 
Monkey 1 (Mk1) performed an average of 92% of DPX trials correctly and Monkey 2 
(Mk2) performed an average of 90% of trials correctly. For both monkeys, performance 
varied as a function of trial type (Chi Squared Test: Mk1: AX=93%, AY=96%, BX=80%, 
BY=99%, Χ2=269.41, p<0.001; Mk2: AX=90%, AY=92%, BX=83% BY=99%, X2=364.81, 
p<0.001). There was an increased error rate on BX trials in both monkeys, indicating 
they occasionally released the prepotent target response to the X-probe. However, 
performance was maintained at 80% correct or greater for each of the trial types (Fig. 
2.1D). Reaction time (RT) varied significantly based on the trial type for both monkeys 
(Fig.1E; Kruskal-Wallis test; Mk1 X2 =2640.73, p<0.001; Mk2 X2 =1401.61, p< 0.001). 
Post Hoc testing using multiple comparisons of mean ranks (p<0.01) indicated that for 
Mk1 RTs were significantly different across trial types, with RT being greatest on AY 
trials. Mk 2 RTs for A-cue trials were significantly longer than B-cue trials and RT was 
greatest on AX trials (BX and BY were not significantly different from each other).  
 
Neural Database  
I recorded 48 neural ensembles in the PFC and MD simultaneously, during the 
performance of one balanced and one prepotent set each. A total of 1,105 neurons in 
the PFC and 1,402 neurons in the MD (Mk1: 29 ensembles of 577 PFC neurons and 887 




recorded. This included an average of 29 neurons in the MD (range 16 to 50) and 23 
neurons in the PFC (range 9 to 52) per ensemble. In order to target the PFC and MD 
reliably and reproducibly, I inserted a grid into each recording chamber (Fig 2.2A, B, 
small black circles within each chamber indicates grid hole locations). Each recording 
location (Fig. 2.2A, B, red circles) produced between 1 – 6 ensembles (average of 2 
ensembles per recording day). I confirmed that electrode penetrations successfully 
reached the MD by obtaining CT images of a metal probe inserted to the depth of the 
MD during neural recording inserting and co-registering the CT images with the pre-
surgical MR images (Fig. 2.2C, D).  
 
Neurons encoding cue, probe, and response in MD and PFC  
I applied ANCOVA to identify neurons in which firing rate varied significantly (p < 
0.05) as a function of the cue (A vs. B; during the cue, delay, or probe periods), the 
probe (X vs. Y; during the probe period), or the response (T vs NT; during the response 
period). Both the PFC and the MD contained neurons that significantly modulated their 
firing rates depending on the cue (Fig. 2.3, light blue), the probe (pink), and response 
(purple). Across the population of sampled neurons, 71% of PFC neurons and 84% of 
MD neurons exhibited cue, probe or response-selective activity. The proportion of 
sampled neurons that encoded task-related information was significantly higher in the 
MD than the PFC (Z-test of proportions; Z = -7.63, p < 0.01). The PFC (86%) and the 
MD (84%) had similar proportions of neurons that encoded cue information (Fig. 2.3A, B, 
blue circles; Z = 1.44, p = 0.15). The proportion of probe-selective neurons were 
significantly higher in MD (40%); Fig. 2.3A, B pink circles) than PFC (Z = -4.20, p < 




neurons (66%) than the proportion in the PFC (48%; Z = -7.57, p < 0.001; Fig. 2.3A, B, 
purple circles). Overall, this data indicated variation in MD and PFC neural population 
recruitment for the encoding of the probe and response and similar recruitment for cue 
encoding.  
Bar graphs in Figure 2.3 illustrate the numbers of cue, probe, and response-
selective neurons that preferred A vs B-cues, X vs Y-probes, and T vs. NT responses in 
the PFC (Fig. 2.3C) and the MD (Fig. 2.3D). Cue neurons were split into three groups 
depending on the trial epoch during which their activity was significantly modulated by 
the cue. Early cue neurons (selective during the cue period) were biased to prefer B-
cues in the PFC (Z = -2.43, p < 0.05) and the MD (Z = -11.17, p < 0.001). This bias 
switched during the probe period – late cue neurons were biased to prefer A-cues in 
both areas (PFC: Z = 7.04, p < 0.001; MD: Z = 8.41, p < 0.001). In the delay period, PFC 
neurons were biased to prefer A-cues (Z = 5.56, p < 0.001), whereas MD neurons were 
biased to prefer B-cues (Z = 2.15, p < 0.05). In the PFC probe neurons were significantly 
biased to prefer Y-probes (Z = -3.66, p < 0.001) and response neurons were significantly 
biased to prefer nontarget responses (Z = -3.49, p < 0.001). MD probe and response 
neurons did not show these biases (probe: Z = -1.39, p = 0.164; response: Z = -0.90, p = 
0.368). 
 
Individual neuron activity patterns during the DPX task  
Next, I examined the diversity of firing patterns of individual neurons by plotting 
rasters and spike density functions (SDFs) of their activity separated by cue-probe 
sequence (trial type) in PFC (Fig. 2.4A-C) and MD (Fig. 2.4D-F). Some neurons 




Other neurons modulated their firing rate in response to multiple task factors during 
multiple trial periods. For example, the PFC neuron in Figure 2.4A primarily modulated 
firing rate during the cue period (B-cue preference), whereas the PFC neuron in Figure 
4B modulated firing rate during both the cue period (B-cue preference) and the probe 
period (A-cue preference). I refer to neurons exhibiting early (cue period) B-cue 
preference and late (probe period) A-cue preference as ‘switch neurons’, as was 
reported previously (Blackman et al., 2016). I found that switch neurons exist also in the 
MD thalamus (Fig. 2.4D). Other neurons exhibited selectivity for the probe (Fig. 2.4E, F) 
and response (Fig. 2.4C). 
 
Population neural activity patterns evoked by the DPX task  
I first examined population activity of neurons separated according to the cue, 
probe or response preference of the neuron in addition to the trial epoch when selectivity 
was evident as detected by ANCOVA (Fig. 2.5). This revealed some general trends in 
population activity. Many ANCOVA-defined neural populations exhibited early B-cue 
preference, either during the cue period or delay period. This gave over to higher levels 
of activity during the probe period on A-cue trials (demonstrating the general ‘switch’ 
pattern in cue preference noted above). In addition, several of the neural populations 
that exhibited the switch pattern exhibited the overall highest activity during the probe 
period on AY trials in particular. Generally, these features of population activity were 
similar in the PFC and MD, suggesting that neurons in both areas were activated by 
stimulus combinations that instructed the necessity to override the prepotent, target 
response. Therefore, activity in these neurons generally correlated with the necessity to 




task stimuli at different times in the trial, populations defined by significant ANCOVA 
results often exhibited similar activity profiles. Therefore, I combined populations with 
similar activity patterns into functional groups. This allowed for a more simplified 
classification without the loss of information contained within each group, as has been 
done with previous data sets recorded during DPX performance (Blackman et al., 2016). 
I adjusted this previously defined grouping scheme to account for the new activity 
patterns found in the MD. Neurons were assigned to one of seven non-overlapping 
functional groups based on the task factor significantly modulating their respective 
activity (cue, probe, or response), the trial period that activity modulation occurred (cue, 
delay, probe, or response), and the task condition associated with highest activity (A or 
B-cue, X or Y-cue, T or NT-response). 
Group 1 (Fig. 2.6A: MD, and 2.6H: PFC) consisted of neurons with an early A-
cue preference. These neurons exhibited a higher activity rate on A-cue than B-cue 
trials. Interestingly, Group 1 neurons in both the MD and the PFC population exhibited 
primarily a suppression of activity compared to the fixation period on B-cue trials.  
Group 2 (Fig 2.6B: MD, and 2.6I: PFC) and Group 3 (Fig 2.6C: MD and 2.6J: 
PFC) populations exhibited the ‘switch’ in cue preference from B-cues during the cue 
period to A-cues during the probe period. Notably, probe period activity was better 
aligned to the onset of the cue (Fig 2.6B, C, I, J, left panels) than the timing of the motor 
response (right panel), suggesting that these neurons don’t play a direct role in motor 
control. Collectively switch neurons comprised a large fraction of task-related neurons in 
both areas. Group 2 was made up of neurons with an early B-cue preference or a late Y-
probe preference and generally exhibited a switch from early B-cue to late AY trial 




preference. These neurons exhibited attenuated B-cue selective activity during the cue 
period that switched to A-cue selective activity during the probe period. The PFC 
population exhibited a decrease in delay period activity relative to baseline on B-cue 
trials (Fig. 2.6J), while the MD population did not (Fig. 2.6C).  
Group 4 (Fig 2.6D: MD and Fig 2.6K: PFC) neurons were those with a preference 
for B-cues during the delay and probe periods. The MD and the PFC populations 
showed strong sustained delay period activity, classically associated with maintenance 
of information in working memory.  
Group 5 (Fig 2.6E: MD and Fig 2.6L: PFC) neurons exhibited X-probe preference 
during the probe period. This group was much more prominent in the MD than the PFC, 
providing a clear distinction between these areas. Activity in Group 5 neurons was better 
aligned with the response (Fig. 2.6E, L; right panel) than probe onset (left panel), 
suggesting a role in response control. 
Group 6 (Fig 2.6F: MD and Fig 2.6M: PFC) and group 7 (Fig 2.6G: MD and Fig 
2.6N: PFC) were made up of neurons exhibiting response selectivity activity for T (Group 
6) and NT (Group 7) motor responses. Neurons exhibiting response-selective activity 
were much more prominent in MD (Fig. 2.6F, G) than PFC (Fig. 2.6M, N), both in terms 
of numbers of neurons and strength of signal. This suggests that MD plays a more direct 
role in response programming and or selection than PFC. 
 
Quantification of the population of switch neurons  
To quantify ‘switch neurons’ in the MD and PFC, I computed cue preference 
indices that captured neural preferences of A vs. B-cues in the cue and probe periods 




significant for the pattern of activity associated with encoding of cognitive control load 
(Early B-cue to late A-cue preference switch; MD - 106 out of 248 neurons encoding the 
cue during both the cue and probe periods; PFC - 70 out of 133) were significantly more 
numerous than neurons that switched in the opposite direction (Early A-cue to late B-cue 
preference; MD - 26 out of 248; PFC - 18 out of 133; Fig. 2.7, red circles vs. blue circles) 
in the PFC (Fig 2.7A; z-test of proportions: Z = 6.78, p<0.001) and MD (Fig. 2.7B; Z = 
6.95, p < 0.001). There were no significant differences in the proportion of significant 
‘switch’ neurons between the MD and PFC (Z = 1.85, p = 0.064).  
 
Influence of cognitive control load on switch neuron activity  
To investigate whether modulation of cognitive control load at the behavioral 
level influenced information processing in the MD-PFC network, I contrasted neural 
activity on balanced and prepotent trial sets. In balanced trial sets, all four cue-probe 
sequences occurred with equal probability. In prepotent trial sets, the majority of trials 
(69%) presented the AX cue-probe sequence, increasing the strength of the target 
response habit (and the level of cognitive control required to override it). During the cue 
period, B-cues were associated with high cognitive control load because they instructed 
countermanding the habitual target response (whereas A-cues established expectancy 
of the target response). During the probe period, preceding B-cues instructed the 
nontarget response regardless of the probe (so that no additional cognitive control was 
required). On A-cue trials, the probe is relevant and dictates which response will be 
correct. The Y-probe countermands the expectation of the target response, so that AY 
trials represent high cognitive control load, whereas AX trials release the habitual target 




firing rate on B-cue and A-cue trials during the cue period, and AY and AX trials during 
the probe period, to provide a measure of the strength of neural signals reflecting 
cognitive control. I then asked whether the strength of these neural signals differed 
between balanced and prepotent trial sets. I found that the B-cue signal (activity on B-
cue minus A-cue trials; Fig. 2.8 blue) in Group 2 and 3 neurons was significantly larger 
(permutation test, p < 0.05) across the population of neurons on prepotent relative to 
balanced trial sets in both the PFC (Fig. 2.8A, C) and the MD (Fig. 2.8B, D). Similarly, I 
found that the AY signal (activity on AY minus AX trials) was significantly larger on 
prepotent relative to balanced trial sets again in both areas (Fig. 2.8A-D, pink). These 
data suggest that the strength of the physiological signals reflecting cognitive control at 
the neural level in both the PFC and MD is augmented when cognitive control demand is 
increased at the behavioral level. 
 
Timing and strength of single neuron recruitment in MD and PFC  
  I compared the timing and strength of cue, probe and response signals in MD 
and PFC neurons at the population level to provide insight into the pattern of information 
flow between the MD and the PFC during cognitive control processing. For that purpose, 
I performed a regression analysis in which I regressed single neuron firing rates in the 
MD and PFC onto the cue (A or B), probe (X or Y), or response (T or NT) over trials 
within a sliding window of 100ms advanced in 20 ms steps. I quantified the strength of 
the relationship between single neuron firing rate and task variables by calculating PEV 
(proportion of explained variance). Heat maps (1 row = 1 neuron) illustrate the time 




response) as a function of time in the trial (Fig. 2.9A, B, C). I ranked neurons according 
to the time of their peak significant regression coefficient and restrict the PFC and MD 
populations to equal numbers of significant neurons to compare the timing of recruitment 
and strength of signals across the population (cue: n = 764, probe: n = 491, response: n 
= 362 neurons in PFC and MD). The bands of peak PEV values in the heat maps in both 
PFC (Fig. 2.9A-C; right) and MD (left) indicate a sequential recruitment of neurons took 
place during the trial in both brain areas, with each neuron modulating its firing rate in 
relation to task variables for a short period of time consistent with a temporally dynamic 
population code (Crowe et al., 2010). Additionally, neurons exhibited more extended 
periods of firing rate modulation (longer horizontal bands of color in the heat maps) 
encoding the cue (Fig. 2.9A) and response (Fig. 2.9C) in both MD (left) and PFC (right), 
consistent with persistent activity reflecting the maintenance of task information in 
working memory. The persistent representation of the response was more apparent in 
MD (Fig. 2.9C, left) than PFC (right), again consistent with a preference for response 
encoding in the MD. To compare the timing of neural recruitment in MD and PFC, I 
compared cumulative distributions of the time to peak PEV of all neurons recruited for 
each task factor. Cue signals emerged significantly earlier in the PFC in comparison to 
the MD (Fig. 2.9D; KS test = 0.18, n = 764 MD and PFC neurons, p<0.001). Probe 
signals emerged earlier in the MD than the PFC (Fig. 2.9E; KS test = 0.15, p <0.001). 
Response signals also emerged earlier in the MD than the PFC (KS test = 0.19, p 
<0.001). To compare the strength of neural recruitment in MD and PFC, I computed the 
population average PEV time course for each task variable and evaluated the 
significance of differences between brain areas using a permutation test (Methods; p < 




and response (Fig. 2.9I) was significantly larger in the MD than the PFC during the probe 
period. There was no significant difference in cue related signals between MD and PFC 
during the cue period (Fig. 2.9G). MD contains much stronger information about all task 
variables during the probe period when it is critical to combine cue and probe information 
to correctly select the response direction. 
 
Timing and strength of population decoding in MD and PFC  
To further elucidate differences in the strength and timing of neural signals 
between the MD and PFC, I conducted a time-resolved decoding analysis to quantify the 
information about task variables encoded by patterns of neural activity in the population. 
In addition to decoding the cue, probe and response with all significant neurons (Fig. 
2.10), I decoded cue and probe from Group 2 and 3 neurons and the response from 
Group 6 and 7 neurons (Fig. 2.11). For the most part, strength and timing patterns were 
maintained across the MD and PFC whether they were obtained with all significant 
neurons (Fig. 2.10) or with the group restricted neurons (Fig. 2.11). In prepotent sets, 
cue decoding posterior probabilities rose in the MD and PFC in parallel but were 
sustained at significantly higher levels during the cue period in PFC, particularly on B-
cue trials (Fig. 2.10A and Fig. 2.11A, p < 0.05, permutation test). During the probe 
period, the converse was true – cue posterior probability was significantly greater in MD 
than in PFC (Fig. 2.10A and Fig. 2.11A), perhaps reflecting the stronger late-cue signals 
in MD (Fig. 2.6C, compare 2.6J). Similarly, probe posterior probabilities rose for the MD 
and PFC in parallel during the probe period with the MD reaching significantly higher 
level (Fig. 2.10B and Fig. 2.11B, p < 0.05, permutation test). Lastly, response posterior 




rising first to an intermediate level during the cue period (since the cue carried partial 
information about the direction of the response) and rising further after the probe was 
presented (which determined response direction definitively). Response probabilities 
obtained with all significant neurons further demonstrate the fact that the cue contained 
partial information about the forthcoming response direction as the decoding time 
courses were similar between the response and cue decoding time courses (Fig. 2.10C 
compared to Fig. 2.10A). 
 
Functional coupling between neurons coding the cue, probe and response within the 
same brain area 
I next evaluated functional communication between neurons in MD and PFC 
during DPX task performance. For that purpose I applied an analysis my lab developed 
previously to measure transmission of signals containing task-relevant information 
between connected brain areas (Crowe et al., 2013b). This analysis measures temporal 
correlations in the amount of information encoded by different groups of simultaneously 
recorded neurons either within or between brain areas. In this analysis, I first convert 
time varying patterns of neural activity in two non-overlapping sets of neurons into two 
time series of posterior probabilities associated with the neural representation of specific 
task variables. I then ask whether fluctuations in the probability time series are 
correlated at a lag (of ± one 50 ms time bin) within a sliding window (500 ms). 
Transmission time series capture the strength of this correlation (indexed by the F 
statistic in a regression analysis). Signal transmission occurs between the two sets of 
neurons when the transmission time series exceeds 95th percent of the bootstrap 




 I first consider signal transmission between groups of neurons coding different 
task variables within PFC and MD. I detected significant signal transmission between 
distinct subsets of simultaneously recorded neurons that encoded the cue, probe and 
response. This may reflect integration of these signals needed to mediate logical 
operations (analogous to ‘if-then’) necessary to implement the contingencies of the DPX 
task. In the PFC, I observed generally a pattern of signal transmission that bore 
resemblance to the activity of switch neurons, in the sense that neural signals inverted 
between cue and probe periods of the task (in this case, referring to the direction of 
signal transmission between subsets of neurons). This was seen for communication 
between cue and probe neurons (Fig. 2.12A), where transmission from cue to probe 
(blue) occurred late and from probe to cue (pink) early in the trial. Likewise, signal 
transmission inversion was seen in the case of communication between cue and 
response neurons (Fig. 2.12C) and probe and response neurons, which inverted at the 
end of the delay period (Fig. 2.12E). In the MD, this generally held for cue-response (Fig. 
2.12D) and probe-response coupling (Fig. 2.12F) but the inversion occurred during the 
delay period instead of the probe period. Unique to the MD, cue and probe coupling in 
both directions was restricted to the probe period. 
 
Functional coupling between neurons in MD and PFC  
I next considered task-related signal transmission between neurons encoding the 
same task variable in MD and PFC to measure communication in thalamocortical 
networks during cognitive control. I observed instances wherein the direction of 
information flow between these areas switched from cue to probe period (as I saw 




the bottom-up direction during the cue period and top-down direction during the probe 
period (Fig. 2.13A). Similarly, signal transmission between response neurons was both 
bottom-up and top-down during the cue period but only top-down during the probe 
period (Fig. 2.13C). Although transmission of probe signals appeared to be strong, it was 
not significant when compared to the bootstrap distribution generated by trial shuffling, 
indicating that there were time-locked events that occurred across all trials, unrelated to 
the task information contained in the network (Fig. 2.13B).  
Next, I looked at signal transmission between the MD and PFC with neurons 
encoding different task variables. Significant signal transmission between MD cue and 
PFC probe neurons occurred in both top-down and bottom-up directions during the cue 
period and bottom-up at the end of the delay period (Fig. 2.14A). There was a short 
instance of bottom-up signal transmission from MD cue neurons to PFC response 
neurons in the delay period (Fig. 2.14C). Significant top-down signal transmission from 
PFC cue to MD response neurons occurred during the cue and delay periods (Fig. 
2.14D). Finally, there was significant bottom-up signal transmission from MD response 
neurons to PFC probe neurons in the cue period (Fig. 2.14F). Otherwise signal 
transmission between neurons coding different task variables in the two structures was 
absent. Taken together, this data suggest that the distribution of signals between PFC 
and MD may be achieved by the transmission of certain signals and at certain periods of 
the trial (mostly relating to the cue and response during the cue and response periods) in 








MD has long been considered an important nodal point in cognitive functions 
mediated PFC distributed networks due to their reciprocal connection (Goldman-Rakic 
and Porrino, 1985; Xiao et al., 2009), the fact that MD lesions often produce PFC-like 
cognitive deficits (Isseroff et al., 1982; Zola-Morgan and Squire, 1985; Parker et al., 
1997; Van der Werf et al., 2000; Van der Werf et al., 2003; Zoppelt et al., 2003), and the 
presence of similar neural signals in the two structures during cognitive processing in 
primates (Fuster and Alexander, 1971, 1973; Funahashi et al., 2004; Watanabe and 
Funahashi, 2004a, b). To better understand MD-PFC interactions as related to cognitive 
control deficits in schizophrenia, and to establish the knowledge base necessary to 
develop new treatments targeted at improving MD-PFC communication with follow on 
benefits for cognitive function, I translated a task measuring cognitive control deficits in 
patients to monkeys and report here the pattern of neural activation and communication 
between MD and PFC during its performance. Toward that goal, I showed that (1) state 
signals (encoding countermand probability) were found in the MD and were similar to 
state signals in PFC, (2) working memory signals were distributed between the MD and 
PFC, (3) response signals were enriched in MD relative to PFC and more balanced 
between the two responses in the task (prepotent and counter-habitual), and (4) 
information about task variables was transmitted between different groups of neurons 
both within and between MD and PFC. 
 
State (countermand) signals  
Neurons that encode ‘state’ (the probability of having to override the prepotent 




(cue and probe periods, respectively) are also found in MD and were similar to their PFC 
counterparts. State signals were earlier and stronger during the cue period in PFC in 
comparison to MD (Fig. 2.9A, D, G; 2.10A; 2.11A), but in both structures were biased to 
prefer the B-cue early and A-cue late in the trial (Fig. 2.3C, D), exhibited similar patterns 
of neuronal activity at the single neuron (Fig. 4B, D) and population levels (Fig. 2.6B, C, 
I, J; Groups 2 and 3), modulated their level of firing in relation to cognitive control load 
(Fig. 2.8), and were equally prevalent among cue-responsive neurons in both structures 
(Fig. 2.7). The presence of neurons that directly reflect cognitive control operations in the 
MD has not been well explored in primates. A key aspect of cognitive control is the 
ability to adjust one’s response to a single stimulus based on the contextual information 
provided and to inhibit perseverative responses within tasks that produce/exploit habitual 
responding patterns. The MD has been implicated in behavioral flexibility by lesion and 
inactivation studies in rodents (Block et al., 2007; Parnaudeau et al., 2013; Parnaudeau 
et al., 2015; Schmitt et al., 2017) and humans (Van der Werf et al., 2000; Van der Werf 
et al., 2003) demonstrating that MD lesions cause an increase in perseverative behavior 
during tasks that require shifting of behavioral strategies. Lesions in monkeys have 
indicated dysfunctional strategy adaptation in reversal learning tasks (Chudasama et al., 
2001; Chakraborty et al., 2016). However, the role of the MD has not yet been explored 
in a cognitive control task like the DPX task or at the cellular level. A previous study 
reported that local field potentials (LFPs) in the PFC exhibit increased activation in 
response to B-cues early in the trial and AY-trials late in the trial (Dias et al., 2006). This 
is similar to the neural preference biases and spiking activity patterns I report here in the 
MD and PFC, however the prior study did not look at PFC neurons at the spiking level. 




the PFC, referred to as switch neurons as their cue preference switches from B-cue in 
the cue to A-cue in the probe periods of the trial, often with an additional increment in 
activity on AY trials (Blackman et al., 2016). Essentially, these neurons reflect cognitive 
control because they increase their activity at different times in the trial in response to 
different stimuli (or stimulus combinations) that collectively signal an increase in the 
probability that it will be necessary to countermand the habitual target response at the 
end of the trial. The activity of switch neurons is better aligned to the visual stimuli than 
the motor response, suggesting they are involved in estimating environmental state 
(countermand probability) rather that encoding the motor response itself. In the current 
study I found switch neurons in the MD, providing to my knowledge the first evidence of 
a neuronal marker of cognitive control in this thalamic structure.  
 
Working Memory signals  
 In addition to switch neuron activity encoding state in MD, I also found MD 
neurons that exhibit persistent activity classically associated with working memory, 
particularly on B-cue trials (Fig. 2.5G, Fig. 2.7D, K), information about the cue is 
maintained throughout the delay period (Fig. 2.10) and neurons encoding the cue are 
continuously recruited throughout the delay period (Fig. 2.9). The primate MD has been 
implicated in working memory on the basis of lesion experiments (Isseroff et al., 1982; 
Zola-Morgan and Squire, 1985; Parker et al., 1997). MD neural recording experiments 
have furthered our understanding of the information contained in the MD during delay 
periods of spatial working memory tasks and identifying the MD as a co-contributor to 
working memory function alongside the PFC. This is due to the fact that the MD contains 




delay response task, delayed matched to sample task, and a go/no-go task similarly to 
their PFC counterparts. (Fuster and Alexander, 1971, 1973; Tanibuchi and Goldman-
Rakic, 2003; Watanabe and Funahashi, 2004b, a; Tanibuchi et al., 2009b; Watanabe et 
al., 2009; Watanabe and Funahashi, 2018). Additionally, inactivation of PFC decreases 
MD signals related to working memory (Alexander and Fuster, 1973; Bolkan et al., 2017; 
Schmitt et al., 2017), and inactivation of MD decreases PFC delay period activity as well 
(Bolkan et al., 2017; Schmitt et al., 2017). My data add to this prior evidence that MD 
and PFC jointly participate in the network basis of working memory and further support 
of the MD’s involvement in working memory in general, not just in spatial working 
memory.  
 
Decision and response signals  
The most notable differences between the activity of MD and PFC neurons 
related to signals encoding the motor response. Motor response signals were stronger 
(Fig. 2.9I; Fig. 2.10C; Fig. 2.11C), more frequent (Fig. 2.3A), and emerged earlier (Fig. 
2.9F) in MD compared to PFC. Additionally, the population representation of the 
response in MD was more balanced between neurons preferring target (habitual) and 
the nontarget (counter-habitual responses), whereas PFC neurons were preferentially 
engaged for nontarget responses (Fig. 2.3C, D; Fig, 2.6F, G, M, N). Prior neural 
recording studies in monkey MD and PFC during an oculomotor delayed response task 
provided consistent evidence of a stronger role of MD in motor programming (Sommer 
and Wurtz, 2004b, a; Watanabe and Funahashi, 2004a; Tanibuchi et al., 2009b; 
Watanabe et al., 2009; Watanabe and Funahashi, 2018). In a series of studies, more 




transform working memory signals from stimulus-based to response-based spatial 
coding during the delay period earlier than the PFC (Watanabe and Funahashi, 2004a; 
Watanabe et al., 2009; Watanabe and Funahashi, 2018). The MD has also been 
implicated to be update the cortex about motor responses by conveying corollary 
discharge of motor plans (Sommer and Wurtz, 2004b, a).  
Unlike prior studies, in the DPX task response direction is dictated conditionally 
by combinations of (cue and probe) stimuli. Consistent with a stronger role in response 
selection in the MD, I found that ‘late’ cue signals (neural signals that ramped up to the 
probe period but encoded the identity of the preceding cue) were stronger in MD than 
PFC (Fig. 2.9G; Fig. 2.10A; Fig 2.11A). In addition, MD probe signals emerged earlier 
(Fig 2.9E), were stronger (Fig. 2.9H; Fig. 2.10B; Fig. 2.11B), and were more balanced in 
their preference for X and Y-probes (Fig. 2.3 C, D) compared to probe signals in PFC. 
The relative enhancement of late cue and probe signals in MD suggests a more direct 
role in combining these signals to correctly select a response (target or nontarget). One 
prior study did look at thalamocortical relay neurons in the MD that project to the PFC 
and found that these neurons encode stimulus information and also the impending motor 
response (Tanibuchi et al., 2009b). Put together, a picture of the MD’s role in response 
selection begins to emerge. In addition to inputs from the PFC, the MD also receives 
anatomical inputs directly from the basal ganglia, specifically the globus pallidus interna 
and the substantia nigra reticulata (Alexander et al., 1986; Haber and McFarland, 2001; 
Haber and Calzavara, 2009). This basal ganglia projection to the MD has been thought 
to be involved in a loop of information about impending behavioral responses (Haber 
and McFarland, 2001; Tanibuchi et al., 2009b) and potentially contains information 




play a large role in habit formation (Yin and Knowlton, 2006). Therefore, the MD may be 
a node in a distributed response selection network where information about habitual 
responses from the basal ganglia and state-based responses from the PFC converge to 
mediate the competition between habit and cognitive control.  
 
Neural communication  
The DPX task requires an ‘if-then’ conditional computation (e.g. if A-cue and X-
probe, then target response). Implementing this logical operation in a neural circuit is 
likely to involve physiological interaction between groups of neurons encoding cues, 
probes and responses (because the decision how to respond was contingent on 
combinations of cues and probes). By analyzing temporal correlations in coded 
information, I found that neurons in the PFC and the MD that encoded the state 
transmitted information to probe and response neurons within their respective local 
circuits (Fig. 2.12), indicating within area physiological interactions required for logical 
operations. Additionally, I found evidence that neurons encoding state in PFC (as 
instructed by cues) provided top-down input to MD neurons and that this interaction was 
reciprocal (Fig. 2.13A, 2.14D). In addition, PFC neurons transmitted information about 
the response to MD when the response decision was being made (Fig. 2.13C). Studies 
have looked at spike phase locking to local field potentials (LFPs) between the MD and 
PFC during working memory performance (delayed nonmatch to sample T-maze task) 
(Parnaudeau et al., 2013; Bolkan et al., 2017). They reported that mPFC spikes lock to 
MD beta oscillations: mPFC spikes lag during the delay period, indicating a MD-mPFC 
drive, mPFC spikes lead during the choice phase, indicating a mPFC-MD drive (Bolkan 




strongest at the time the animal makes its response choice. However, there are no 
studies looking at functional coupling of MD-PFC neurons during context processing task 
performance at the cellular level in both areas. My data indicate that neurons in the MD-
PFC network transmit information both in the top-down and bottom-up directions at 




 In conclusion, I found that the MD contains neurons that reflect logical 
operations as they relate to performance on a context processing task and serves a 
response selection node within the network. Differences in the state of the network 
between situations of high and low cognitive load indicate that the PFC is involved when 
cognitive demand is high, represents cue information early on, and transmits information 
to the MD when it comes online for response selection. The MD, on the other hand, 
plays a more balanced role in representing both habitual and counter-habitual 
responses, and may participate in the mediating the competition between them. In 
patients with Schizophrenia the MD is typically smaller (Pakkenberg, 1992; Popken et 
al., 2000; Young et al., 2000), has decreased activation during performance of cognitive 
control tasks that is correlated with decreased activation of the PFC (Minzenberg et al., 
2009), and has decreased connections with the PFC (Welsh et al., 2010; Woodward et 
al., 2012; Anticevic et al., 2014b; Anticevic et al., 2014a). These data suggest the MD-
PFC network is particularly affected by the disease. Since the MD projects broadly to 
PFC, treatments that target this nucleus could have wide-ranging modulatory effects on 







Figure 2.1. The DPX task and behavioral performance. A. Cue-probe sequence on 
AX and BX trials. The cue was presented for 1.0 s, followed by a 1.0 s delay period, 
followed by a 0.5 s presentation of the probe. The monkey could respond from probe 
onset until 0.5 s following probe offset. The intertrial interval was 1.1 s. Top Row: ‘AX’ 
valid sequence requiring leftward (target; T) joystick movement. Bottom Row: ‘BX’ invalid 
sequence requiring rightward (nontarget; NT) movement. (ITI: intertrial interval). B. All 
cue and probe dot patterns used. A-cue and X-probe consisted of a single dot pattern 
each, while B-cues and Y-probes consisted of 5 different dot patterns each. C. The 




stimuli. The combination of an A-cue and an X-probe required the target, left (L) 
response. All other combinations (AY; BX; BY) required a nontarget, right (R) response. 
D, E. Mean (±2 standard error of the mean, SEM) proportion of trials correct (D) and 
reaction time in seconds (E) is shown split by trial type (cue-probe sequence) and by 
monkey (Mk 1 - open circles and dashed lines; Mk 2 - closed circles and solid line). 




Figure 2.2. Reconstructions of electrode array recording sites. A, B. Two-
dimensional (2D) reconstructions of chamber and grid locations (red dots indicate 
recording sites) superimposed on a dorsal view of sulcal anatomy in Mk1 (A) and Mk 2 
(B). MD: Mediodorsal nucleus of the thalamus, PS: Principal sulcus, AS: Arcuate sulcus, 
CS: Central Sulcus, IPS: Intraparietal sulcus. C, D. Images show superposition of 
electrode penetration (gray line through blue chamber) targeting MD in three-
dimensional (3D) reconstruction of MR image sequence with co-registered CT images in 




thalamic chambers. Yellow region indicates location of MD in the Cicerone brain atlas 














Figure 2.3. Numbers of neurons selective for cue, probe and response in MD and 
PFC. A, B. Venn diagrams depict the numbers of neurons exhibiting significant 
selectivity (ANCOVA, p < 0.05) for the cue (blue), probe (pink), and/or response (purple) 
in MD (A) and PFC (B). Area of circles is proportional to neuron number. C, D. Bars 
indicate the number of neurons in the PFC (C) and MD (D) that exhibit preference for 
specific cues (A or B), probes (X or Y), and responses (T or N). Asterisks indicate 
significant biases in preference for specific cue, probes, and responses in the neural 













Figure 2.4. Single neuron activity during DPX task performance. Each row of panels 
illustrates the activity of a single neuron in PFC (A-C) or MD (D-F). Individual panels 
indicate activity on a single trial type defined by cue-probe sequence. Rasters indicate 
timing of action potentials, spike density functions (solid gray;  = 40 ms; 10 Hz/div) 
show modulations in average firing rate. Red tick marks indicate the time of the 
response in each trial. A. Early B-cue neuron: PFC cell 4623 is an example of a neuron 
whose firing rate during the cue period is greater on B-cue trials than A-cue trials. B. 
Early B-cue and Late A-cue neuron. PFC cell 5175 is an example of a ‘switch’ neuron 
that switches its cue preference from B-cues during the cue period to A-cues during the 
probe period. C. Early B-cue and NT-response neuron: PFC cell 5445 is an example of a 
neuron whose firing rate is greater on B-cue than A-cue trials during the cue period and 
is also greater on invalid NT-response than T-response trials during the response period. 
D. Early B-cue and Late A-cue neuron: MD cell 4488 is an example of a ‘switch’ neuron 
that switches its cue preference from B-cues during the cue period to A-cues during the 
probe period. E. X-probe neuron: MD cell 5486 is an example of a neuron whose firing 
rate during the probe period is greater on X-probe than Y-probe trials. F. Early B-cue 
and Y-probe neuron: MD Cell 5372 is an example of a neuron whose firing rate during 
the cue period is greater on B-cue than A-cue trials, and during the probe period is 










Figure 2.5. Task-defined population activity patterns on prepotent trial sets. 
Population spike density functions (SDFs; δ = 40 ms) display average population activity 
as a function of time on subsets of trials defined by cue-probe sequence (AX: orange, 
AY: red, BX: purple, BY: blue). Neurons are assigned to populations in this figure based 
on their cue, probe, and response preference as well as the trial epoch in which activity 
was modulated as determined by ANCOVA (p<0.05). Each neuron could belong to 
multiple populations so defined. The left column of panels (A-E) illustrate the activity of 
populations that preferred valid stimuli and responses (A-cue, X-probe, T-response). The 
right column of panels (F-J) illustrate the activity of populations that preferred invalid 




population activity are shown on the left and right, respectively. All SDFs are aligned to 
the cue onset. The stimulus or response preference defining each population is 


























Figure 2.6. Population activity patterns in functionally defined neural groups in 
prepotent trial sets. Population spike density functions (SDF; δ = 40 ms) display 
average population activity patterns on subsets of trials defined by cue-probe sequence 




overlapping functional groups (see Results text) depending on the specific preference for 
individual cues, probes and responses as well as the trial period that neurons exhibited 
selective activity as defined by ANCOVA. Population activity in MD (A - G) and PFC (H - 

























Figure 2.7. Quantification of switch in cue preference from the cue to the probe 
period in single neurons on prepotent trial sets. I computed an index quantifying cue 
preference (B-cue – A-cue) / (B-cue + A-cue) using cue and probe period firing rates for 
each neuron. A, B. Colored symbols indicate neurons with a significant switch from B-
cue to A-cue preference between the cue and probe periods (red circles), or the 
opposite switch in preference (blue circles). Gray symbols indicate neurons that encoded 
the cue during both cue and probe periods but did not switch preference. Data are 
displayed separately for PFC neurons (A) and MD neurons (B) recorded during the 










Figure 2.8. Modulation of cognitive control neural signals with cognitive control 
load. Blue shading indicates difference in cue period firing rates on B-cue and A-cue 
trials. Pink shading indicates difference in probe period firing rates on AY and AX trials. 
A, B. Population activity of Group 2 neurons in PFC (A) and MD (B) on balanced (left) 




and MD (D) on balanced (left) and prepotent (right) trial sets. Asterisks (*) indicate a 
significant increase in the difference in cue period firing rate on B-cue and A-cue trials on 
prepotent relative to balanced trial sets (p < 0.05, permutation test). Pound symbols (#) 
similarly indicates a significant increase in the difference in probe period firing rate on AY 





















Figure 2.9. Proportion of explained variance (PEV) in firing rate over trials as a 
function of time in prepotent trial sets. A-C. Warmer colors in the heat maps 
represent greater PEV values associated with the cue (A), probe (B), and response (C). 
Neurons were ranked according to the time of their peak significant regression 
coefficient during the trial and populations in MD and PFC were restricted to equal 
numbers of significant neurons to facilitate comparison of the timing of neural 
recruitment between brain areas. PEV values were obtained by regressing the firing rate 
of each neuron onto the appropriate task factor over trials within a sliding 100 ms 
window (advanced in 20 ms steps). MD data is on the left and PFC data on the right. D-
F. Cumulative distributions of time to peak PEV attributable to the cue (D), probe (E), 
and response (F) in MD neurons (blue) and PFC neurons (red). G-I. Population average 
PEV attributable to the cue (G), probe (H), and response (I) in MD neurons (blue) and 
PFC neurons (red). Significant differences in population average PEV time courses are 





Figure 2.10. Time-resolved population decoding of cue, probe and response MD 
and PFC neurons using all significant neurons. Functions plot the population 
average posterior probability associated with the neural representation of the cue (A), 
probe (B), and response (C) as a function of time in the trial, based on neural population 




panels illustrate posterior probability averaged over all trials, center and right panels plot 
posterior probability averaged over the subsets of trials indicated above. Horizontal 
dashed lines indicate chance decoding based on the prior probabilities of cue, probe and 
response in prepotent trial sets. Circles indicate significant differences in decoding 
strength between areas (p < 0.05, MD > PFC in blue, PFC > MD in red, permutation test, 
FDR corrected, Methods). Dashed lines indicate prior probabilities. For example, before 
the cue appeared and neural signals encoding the cue developed, the prior probability of 
the A-cue was 0.81 (AX and AY trials comprised 81% of trials in prepotent sets). 











Figure 2.11. Time-resolved population decoding of cue, probe and response MD 
and PFC using neurons in Groups 2 and 3. Functions plot the population average 
posterior probability associated with the neural representation of the cue (A), probe (B), 
and response (C) as a function of time in the trial, based on neural population activity in 
MD (blue) and PFC (red). Neural data recorded on prepotent trial sets. Left panels 




posterior probability averaged over the subsets of trials indicated above. Horizontal 
dashed lines indicate chance decoding based on the prior probabilities of cue, probe and 
response in prepotent trial sets. Circles indicate significant differences in decoding 
strength between areas (p < 0.05, MD > PFC in blue, PFC > MD in red, permutation test, 
FDR corrected, Methods). Dashed lines indicate prior probabilities. For example, before 
the cue appeared and neural signals encoding the cue developed, the prior probability of 
the A-cue was 0.81 (AX and AY trials comprised 81% of trials in prepotent sets). 


















Figure 2.12. Task signal transmission between subsets of neurons within MD and 
PFC encoding the cue, probe and response. Functions illustrate the time course of 
signal transmission between subsets of neurons located within the same brain area that 
encoded different task variables. The direction of signal transmission between neural 
subsets is indicated by color (see legend above each column). Circles indicate time 
points where the strength of transmission was significantly nonzero, defined as time 
points where the F-statistic exceeded the 95th percentile (FDR corrected) of a bootstrap 
distribution of F-statistics at that time point generated after shuffling trials of posterior 
probability time series to break the simultaneity of the underlying neural data and 
repeating the regression analysis. A, C, E. Transmission between subsets of neurons in 
prefrontal cortex encoding the cue and probe (A), cue and response (C) and probe and 







Figure 2.13. Signal transmission between PFC and MD neurons encoding the 
same task variable. Functions plot is the time course of transmission of (A) cue, (B) 
probe, and (C) response signals between neurons in the MD and PFC. Top-down (PFC 
to MD) transmission in red and bottom-up (MD to PFC) in blue. Signal transmission is 
indicated by circles, where regressions were significantly above the bootstrap 
















Figure 2.14. Signal transmission between PFC and MD neurons encoding different 
task variables. Functions illustrate the time course of signal transmission between 
subsets of neurons located in different brain areas that encoded different task variables. 
The direction of signal transmission between neural subsets is indicated by color (see 
legend above each column). Circles indicate time points where the strength of 
transmission was significantly nonzero. A, B. Signal transmission between (A) PFC 
probe and MD cue neurons, and (B) MD probe and PFC cue neurons. C, D. Signal 
transmission between (A) PFC response and MD cue neurons, and (B) MD response 
and PFC cue neurons. E, F. Signal transmission between (A) PFC response and MD 








Thalamocortical dynamics in a schizophrenia-relevant state: Disruption of MD-




Functional imaging studies have shown that cognitive control deficits in patients 
with schizophrenia (SZ) are correlated with decreased activation within and functional 
coupling between the mediodorsal nucleus of the thalamus (MD) and the prefrontal 
cortex (PFC) (Minzenberg et al., 2009; Welsh et al., 2010; Woodward et al., 2012; 
Anticevic et al., 2014b; Anticevic et al., 2014a). However, little is known about how 
neural activity, information processing, and network dynamics are affected at the cellular 
level in the MD and PFC by the disease. To begin to understand how neurons in the MD 
and PFC are functionally changed in a SZ-like disease state, I blocked NMDA receptors 
while monkeys performed a cognitive control task and related changes in neural activity 
and network dynamics to patient-like cognitive deficits in monkeys’ performances on the 
dot pattern expectancy task (MacDonald et al., 2005a; Jones et al., 2010). I found that 
blocking NMDA receptors (NMDARs) caused a decrease in the number of neurons 
encoding task state (defined as the probability of having to produce the counter-habitual 
response) in the MD and PFC and that the state neurons that did emerge were delayed 
in their recruitment. Additionally, NMDAR blockade decreased the strength of the neural 
signals encoding task state at both the single neuron and population levels, although the 




representation predicted task failure on a trial-by-trial basis more strongly in MD than 
PFC. NMDAR blockade strongly attenuated transmission of information in local circuits 
from state neurons to probe and response neurons in the PFC more than in the MD. 
Finally, repeated NMDAR blockade chronically disrupted both top-down and bottom-up 
information transmission of task state information between the PFC and MD. These data 
provide new insight into how NMDAR synaptic failure is thought to contribute to cognitive 
deficits in schizophrenia. 
 
INTRODUCTION 
Cognitive deficits in patients with schizophrenia (SZ) are wide-ranging, 
debilitating, and present regardless of illness stage or medication (Servan-Schreiber et 
al., 1996; MacDonald et al., 2005b; Jones et al., 2010; Lesh et al., 2011). The severity of 
cognitive deficits predicts functional outcome for patients (Green et al., 2000; Green et 
al., 2004; Green, 2006; Ventura et al., 2009), however current therapeutics do not 
effectively improve them (Mortimer, 1997; Stip et al., 2005). Dysfunction in cognitive 
control is likely due to the inability of patients to use internally stored goals and rules to 
flexibly produce an appropriate behavioral outcome, a process that is dependent on the 
coordination of central representations of context with sensory inputs and motor outputs. 
This is due to dysfunction across multiple neural systems from genetic abnormalities 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014) to 
structural abnormalities (Kolluri et al., 2005; Lewis and González-Burgos, 2008; Dorph-
Petersen and Lewis, 2017) to large scale network activity (Fornito et al., 2012; Sheffield 
and Barch, 2016). The dorsolateral prefrontal cortex (PFC) has been implicated as the 




multiple other brain regions to influence behavioral outcomes via appropriate action 
selection (Miller and Cohen, 2001; Roy et al., 2010; Goodwin et al., 2012; Mante et al., 
2013). Patients with SZ exhibit decreased activation of the dorsolateral PFC in fMRI 
studies during performance of rule switching (Berman et al., 1986; Weinberger et al., 
1986), context processing (Barch et al., 2003; MacDonald and Carter, 2003; MacDonald 
et al., 2005b; Yoon et al., 2008; Richard et al., 2013), prepotent inhibition (Perlstein et 
al., 2003) and working memory (Glahn et al., 2005; Van Snellenberg et al., 2006; Van 
Snellenberg et al., 2016) tasks. Multiple lines of evidence suggest that these deficits 
extend to include interactions with the mediodorsal nucleus of the thalamus (MD), which 
provides the primary thalamic input to PFC (Goldman-Rakic and Porrino, 1985; Preuss 
and Goldman-Rakic, 1987). For example, in schizophrenia, decreased activation in MD 
and PFC are correlated across patients and tasks during performance of many executive 
functioning tasks (Minzenberg et al., 2009), and the disease is associated with a 
decrease in functional connectivity between the PFC and MD, compared to health 
controls. Additionally, patients with schizophrenia exhibit structural abnormalities in the 
MD (Smith et al., 2011), and post-mortem tissue assessments found loss of dendritic 
spines in layer 3 of the PFC (Kolluri et al., 2005; Lewis and González-Burgos, 2008) that 
are thought to reflect, in part, loss of MD glutamatergic input to PFC (Cobia et al., 2017; 
Dorph-Petersen and Lewis, 2017). Taken together, these data indicate that cognitive 
deficits in schizophrenia likely derive in part from disrupted engagement of this 
thalamocortical network.  
It is not possible to obtain information regarding changes in brain function at the 
cellular level in patients with SZ, necessitating the development of animal models to 




(DPX). The DPX task, and its analogous counterpart the AX-Continuous Processing 
Task, have been used to study cognitive deficits in patients with SZ (MacDonald et al., 
2005b; Jones et al., 2010) due to their ability to expose a specific (as opposed to 
generalized) cognitive deficit in patients, which manifests as the inability to use internal 
representations of state to modify behavioral responses to stimuli (MacDonald et al., 
2005a; MacDonald, 2008). Monkeys trained to perform the DPX task exhibit the same 
behavioral deficit when given acute subanesthetic injections of ketamine or 
phencyclidine (PCP) (Blackman et al., 2013). Using this primate model, I sought to 
determine how information processing in the MD and PFC network is affected at the 
cellular level following drug administration. This information could point to the nature of 
the specific disturbance in cellular activity dynamics responsible for cognitive control 
failure in patients with schizophrenia. In this experiment I recorded from the primate MD 
and PFC, simultaneously, following injections of PCP or saline. I found that NMDAR 
blockade strongly reduced the information about task state (the probability of having to 
produce a counter-habitual response) encoded by neurons in prefrontal cortex, as well 
as delaying their recruitment. Neurons in MD, in contrast, were less affected, with 
signals encoding both the habitual and counter-habitual states and responses persisting 
after NMDAR blockade. Additionally, transmission of information about the task state 
was decreased in both the top-down and bottom-up directions, indicating faulty 
thalamocortical network communication that could contribute to cognitive deficits like 







MATERIALS AND METHODS 
Neurophysiological recording and data analysis methods were as described in 
greater detail in Chapter 2. I describe NMDAR pharmacological manipulation and new 
analyses here.  
 
Subjects 
The same two male monkeys (Macaca Mulatta; 8-11 kg) were used to record 
neurophysiological data. All animal care and experimental procedures conformed to the 
National Institutes of Health guideline and complied with protocols approved by the 
Animal Care and Use committee at the University of Minnesota and the Minneapolis 
Veterans Affairs Medical Center.  
 
The DPX Task and Conditions 
Monkeys were trained to perform the DPX task (Fig. 2.1). Each trial consisted of 
a cue (A or B) and probe (X or Y) dot pattern stimulus, presented in sequence (cue for 
1.0 s and probe for 0.5 s), and separated by a 1.0 s delay period. The cue-probe 
sequence instructed movement direction of the joystick: either the target left response 
left following an AX sequence or a nontarget right response following an AY, BX, or BY 
sequence. Monkeys could respond within a 1.0 s window starting at the onset of the 
probe stimulus and continuing for 0.5 s after probe offset. The intertrial interval (between 
probe offset to the onset of the fixation target for the next trial) lasted 1.1 s. 
Monkeys performed 2 sets of different trial proportions of DPX trials per ensemble of 
recorded neural data: a balanced and a prepotent trial set. Balanced sets contained an 




contained a majority of AX target response trials (69%) with the remained 31% split 
amongst the nontarget trials (AY: 12.5%, BX: 12.5%, and BY: 6%). Prepotent trial 
proportions were replicated from the DPX task and AX-CPT that were administered to 
patients (MacDonald et al., 2005b; Jones et al., 2010). Balanced sets included 80 trials 
for all 53 drug and 43 saline post-drug ensembles. Prepotent sets included 320 or 400 
trials (in 20 and 33 drug ensembles, respectively, and 19 and 24 saline ensembles, 
respectively).  
 
Drug and Saline Injection Protocol 
Here I contrast neural activity under three drug conditions: naïve, drug, and 
saline. In the naïve condition, I recorded neural activity in the MD and PFC either without 
any injection (30 of 48 neural ensembles) or an injection of saline (18 of 48 neural 
ensembles; i.m., Mk1: 0.30mL and Mk2: 0.6mL). (Data from the naïve condition is 
presented in Chapter 2). Once enough neural data in the naïve condition was collected, 
alternating daily injections of phencyclidine (PCP; Sigma-Aldrich Co. LLC; i.m. Mk1: 0.42 
– 0.69 mL; Mk2: 0.26 – 0.32 mL) or saline (i.m. volumes were replicated from the most 
recent PCP injection volume administered to each monkey) commenced. Neural 
recording was conducted after each injection. In contrast to the naïve data, neural data 
in the saline condition was recorded immediately after an injection of saline but after 
initial exposure to PCP on a prior recording day.  
I tested the PCP dose prior to the start of the recording experiment in order to 
determine the correct dosage needed to elicit a consistent deficit over multiple hours of 
the recording session. In Monkey 1 doses of 0.20 mg/kg, 0.25 mg/kg and 0.30 mg/kg 




and 0.18 mg/kg were used for 8 and 12 ensembles, respectively. Following an injection 
of PCP, the recording session began when monkeys were able to maintain eye fixation 
and respond consistently. Drug effects on behavior were gone by the next day and 




Neural recording and signal sorting were completed using the methods described 
in Chapter 2. For this experiment, all neural data recorded in the MD and PFC was 
collected with the ‘Poly2’ vector array electrode geometry (53 drug ensembles and 43 
saline ensembles).  
 
Data Analysis 
In order to assess acute effects of PCP on the neurophysiology underlying 
cognitive control performance I compare neural data collected on PCP days to neural 
data collected on saline days. These saline days were all collected after the initial PCP 
injection (as described above). The Chafee lab previously reported that this drug 
protocol produced chronic changes in PFC local circuit dynamics (Zick et al., 2018). 
Therefore, in order to determine if there were chronic effects on the neurophysiology 
underlying cognitive control performance in the PFC and MD, I compared naive data 








I analyzed the effects of PCP injections on the trial outcome (success or failure) 
as a function of trial type (‘AX’, ‘AY’, ‘BX’, ‘BY’) using a logistic regression. The equation 




) =  𝑏0 +  𝑏1𝐶𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛 +  𝑏2𝑇𝑦𝑝𝑒 + 𝑏3𝐶𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛 ∗ 𝑇𝑦𝑝𝑒 
where ‘Condition’ refers to drug condition (drug vs saline) and ‘Type’ refers to the trial 
type. I applied a two-way ANOVA to reaction time (RT) data on correct trials using drug 
condition and trial type as the factors.   
 
ANCOVA – based classification of neural activity 
I applied analysis of covariance (ANCOVA, p < 0.05) to firing rates of neurons 
recorded during the drug and saline days to detect significant modulation of firing activity 
in relation the cue, probe, and response task variables. I applied separate ANCOVAs 
(listed below) to firing rates in the cue, delay, probe and response windows of the trial. 
Firing rates in the pre-cue fixation period were used as the covariate to control for trial-
by-trial fluctuations in baseline activity. Balanced and prepotent set firing rates were 
combined in the ANCOVA. I applied a one-way ANCOVA to firing rates in the cue and 
delay periods to identify neurons whose activity varied as a function of the cue stimulus 
(A vs. B). I applied a two-way ANCOVA to firing rates in the probe period to identify 
neurons whose activity varied as function of the cue stimulus (A vs. B) or probe stimulus 
(X vs. Y). Lastly, I applied a one-way ANCOVA to firing rates in the response period (± 
200ms centered on the time of the joystick movement) to identify neurons whose activity 




split into separate classifications based on the trial epoch in which their neural activity 
was significantly modulated in response to the cue stimulus: early cue neurons 
modulated their activity during the cue period, delay cue neurons modulated their activity 
during the delay period, and late cue neurons modulated their activity during the probe 
period.  
To determine if there were acute effects on the proportions of significant neurons 
within the MD and PFC, I performed a Z-test of proportions on the counts of neurons in 
different ANCOVA-defined categories in the drug and saline conditions. To determine if 
there were chronic effects of the drug, I performed a Z-test of proportions on counts of 
neurons in the naive and saline conditions. Lastly, I tested whether biases in the 
numbers of neurons preferring different cues (A vs. B), probes (X vs. Y) or responses 
(target vs. nontarget), I performed a one sample Z-test of proportions on counts of 
neurons with each preference in the drug and saline conditions. 
 
Analysis of population average activity 
Continuous estimations of firing rate (population spike density functions, SDFs) 
were obtained via the methods described in Chapter 2. SDFs were generated using the 
‘ksdensity’ function in Matlab with a kernel width of 40 ms. SDFs are presented in the 
functionally defined, non-overlapping groups. Group 1 neurons were cue selective during 
the cue period and preferred the A-cue. Group 2 neurons were cue selective during the 
cue period and preferred the B-cue and/or were probe selective during the probe period 
and preferred the Y-probe. Group 3 neurons were cue selective during delay or probe 
period and preferred the A-cue. Group 4 neurons were similarly defined as Group 3 




period and preferred the X-probe. Groups 6 and 7 were response selective during the 
response period and preferred target and nontarget responses, respectively. 
 
Analysis of cognitive control load dependent neural activity across drug and saline 
conditions 
I examined whether NMDAR blockade affected the degree to which neural 
signals were modulated by cognitive control load. For that purpose, I contrasted the 
activity of Group 2 and 3 ‘switch’ neurons encoding task state (defined as the probability 
that the counter-habitual response will be required based on cues and probes shown) on 
balanced and prepotent trials. Specifically, I computed the difference in mean firing rate 
during trial types that evoked the counter habitual versus habitual responses (B-cue 
compared to A-cue trials during the cue period and AY compared to AX trials during the 
probe period). The significance of cognitive control effects on firing rate modulation was 
determined by a permutation test in which I randomly shuffled firing rates between trial 
sets (balanced and prepotent) recalculating firing rate differences across trial types (100 
iterations). I considered the difference in cognitive control effects on neural activity 
between balanced and prepotent data sets to be significant if it exceeded the 95th 
percentile of the bootstrap distribution (p < 0.05). 
 
Cue Preference Index 
To quantify the influence of drug condition on the propensity of single neurons to 
switch cue preference between the cue and probe periods, I calculated the switch index 
as described in Chapter 2 for neurons that were cue selective during both the cue and 




the cue and probe periods. I then defined the switch index as the difference between 
them. To identify neurons with significant switch activity I performed a permutation test 
by shuffling firing rates between the cue and probe periods (1000 iterations) and 
recalculating the switch index. Neurons were considered to have significant switch 
indices if their index was either greater than the 97.5 percentile, or less than the 2.5 
percentile, of the distribution of the shuffled data (p < 0.05). To determine if the number 
of neurons that significantly switched their cue preference from B-cues in the cue period 
to A-cues in the probe period (task state neurons) were more or less numerous than 
neurons that switched their preference in the opposite direction (from A-cue in the cue 
period to B-cue in the probe period), I performed a Z-test of proportions (p<0.05) 
between proportions of each type of switch neurons in the drug and saline conditions, 
separately. To determine whether NDMAR blockade influenced the prevalence of switch 
neurons in the MD and PFC, I performed a chi-square analysis on 2 X 2 contingency 
tables with counts of switch and nonswitch neurons in the drug and saline (acute) or 
naive and saline (chronic) conditions.  
 
Sliding window regression analysis 
To evaluate the timing and strength of neural signals in the MD and PFC in saline 
and drug conditions, I applied a sliding-window regression analysis. I advanced a 100 
ms wide sliding window at 20 ms steps through firing rates of single neurons on correct 
trials in prepotent and balanced trial sets and then regressed the trial-by-trial firings rates 
onto the cue, probe, and response. The results of the regression analysis were then 
expressed as the proportion of explained variance (PEV) associated with each 




the PFC and MD, I applied a Kolmogorov-Smirnov test to the cumulative distributions of 
the time to peak PEV across the neural populations recorded on drug, saline and naive 
conditions (drug vs saline for acute effects, and saline vs. naive for chronic effects). To 
determine if there was an effect of PCP on the strength of neural signals in the PFC and 
MD, I compared the difference between time courses of population average PEV across 
drug conditions in each area at each time point to a bootstrap distribution of differences 
obtained by randomly shuffling single neuron regression results between the drug 
conditions (1000 iterations; p < 0.05, FDR corrected).  
 
Population decoding analysis 
To quantify information encoded by population activity patterns in the MD and 
PFC about the cue, probe, and response in the drug and saline conditions, I performed 
time-resolved pattern classification (Klecka, 1980; Johnson and Wichern, 1998; Crowe 
et al., 2010) as described in Chapter 2. I measured the firing rates in all significant 
neurons in a sliding window of 150 ms comprised of three consecutive 50ms time bins. I 
decoded the cue, probe, and response on individual trials using a population activity 
vector made up of the mean firing rate of each neuron within the 3-bin window. All trials, 
except the trial being decoded, were used as the training set to compute the mean and 
covariance matrix of population activity patterns for subsets of trials corresponding to the 
potential values (A or B, X or Y, T or NT) of the decoded variable (leave-one-out cross 
validation). I then computed the Euclidean distance between the population activity 
pattern on the decoded trial in a specific time bin and the two group centroids 
corresponding to the two values of the decoded variable computed using firing rates in 




trial belonging to each of the two groups. I assigned that trial to the group with the higher 
posterior probability. I repeated the decoding over time bins at each step in the trial to 
quantify the fluctuations in the strength of population signals encoding task-defined 
information. I defined differences across drug conditions in cue, probe and response 
decoding time courses as significant if they exceeded the 95th percentile (p < 0.05) of a 
bootstrap distribution obtained by randomly shuffling trials of posterior probabilities 
between conditions (drug vs. saline or saline vs. naive; 1000 permutations).  
The decode analysis described above was performed on correct trials only, since 
error trials were sparse in the naive and saline conditions. However, in the drug 
condition there were a significant number of BX errors. To determine the influence of 
elevated B-cue trial errors on neural decoding, I also performed time-resolved pattern 
classification training the classifier using all trials (error and correct combined).  
Finally, I tested whether differences in neural activity could predict the 
commission of behavioral errors on a trial-by-trial basis in the drug condition. For that 
purpose, I decoded trial outcome (correct versus error) from the activity of neurons 
coding task state (Groups 2 and 3), the response (Groups 6 and 7) or all neurons on BX 
trials. I restricted this analysis to neural activity on 15 error and 15 correct trials per 
neuron. I identified differences in outcome decoding time courses between MD and PFC 
as significant if they exceeded the 95th percentile of a bootstrap distribution of 
differences obtained by randomly shuffling trials of posterior probabilities between 







Signal Transmission Analysis 
To determine the effect of PCP exposure on functional connectivity within and 
between the MD and PFC, I applied a signal transmission analysis to sets of 
simultaneously recorded neurons (neural ensembles) (Crowe et al., 2013b). Signal 
transmission analysis captures temporally correlated fluctuations in information about 
task variables encoded by groups of simultaneously recorded neurons. This may capture 
physiological interactions between neurons encoding different task variables such as are 
likely required to implement conditional computations to determine the response in the 
DPX task (for example, if A-cue and X-probe, then target response). To measure signal 
transmission, first I applied time-resolved pattern classification to decode the cue, probe 
and response from subsets of neurons encoding each of these task variables that were 
recorded simultaneously in MD and PFC. This produced posterior probability time series 
associated with the neural representation of each task variable. To obtain unbiased 
estimates of temporal correlation between posterior probability time series, I first 
removed linear trends and autocorrelation in the time series by fitting them with ARIMA 
(autoregressive, integrated moving average) models of order [10,2,2]. I then took the 
residuals from the ARIMA fits. This provided a time series of variation in task information 
coded by the activity of a group of neurons that could not be predicted by its own history 
(autocorrelation) and may therefore reflect the influence of an external input. I then 
determined whether fluctuations in the residual posterior probability time series derived 
from the activity of two groups of neurons (either within or between areas) was 
significantly correlated in time, by regressing one time series onto the other within a 
sliding window of 500 ms advance in 50 ms time steps (at a lag of either plus or minus 




temporal correlation between time series, and hence effective coupling between the 
underlying groups of neurons. Significant coupling was identified at time points (p < 0.05; 
FDR corrected) where F-statistics exceeded the 95th percentile of a bootstrap distribution 
of F-statistics obtained after randomly shuffling post-ARIMA probability time series 





The DPX task consists of four cue-probe sequence trial types (AX, AY, BX, BY; 
Fig. 2.1). Proportion correct data is displayed separated by monkey, trial type, and drug 
condition (Fig. 3.1A). Mk1 performed an average of 87% on all trials during the drug 
condition (AX = 95%, AY = 92%, BX = 41%, BY= 96%) and 94% on all trials during the 
saline condition (AX = 95%, AY = 97%, BX= 82%, BY = 99%). Performance was 
significantly dependent on the drug condition, the trial type, and their interaction (Z-test 
on logistic regression model coefficients: condition: z = 17.62, p < 0.001; trial type: z = 
10.19, p<0.001; condition X trial type interaction: z = 24, p<0.001). Mk2 performed an 
average of 88% correct on all trials during the drug condition (AX = 95%, AY = 83%, BX 
= 60%, BY = 94%) and 92% on all trials during the saline condition (AX = 93%, AY = 
93%, BX = 78%, BY=99%). Performance was significantly dependent on the drug 
condition, the trial type, and their interaction (condition: z = 8.84, p < 0.001; trial type: z = 
14.52, p<0.001; condition X trial type interaction: z = 24.01, p<0.001). Proportion correct 
was significantly dependent on the drug condition and trial type in both monkeys, with 




recreate the BX error phenotype via PCP injections in monkeys used in this experiment 
that mimics BX error behaviors in a previous cohort of monkeys (Blackman et al., 2013) 
and human patients with SZ (Jones et al., 2010). 
RTs were significantly dependent on drug condition, trail type, and their 
interaction for both Mk 1 (condition: F = 248.37, p < 0.001; trial type: F = 273.38, 
p<0.001; condition X trial type: F = 3.91, p<0.01) and Mk 2 (condition: F = 89.021, p < 
0.001; trial type: F = 398.66, p<0.001; condition X trial type: F = 22.26, p<0.01). Overall, 
monkeys were significantly slower across all trial types during the drug condition and 
were slowest on AY trials compared to other trial types during both the drug and saline 
post-drug conditions.  
  
Neural Database 
I recorded 53 ensembles in the PCP drug condition in the PFC and MD 
simultaneously, during the performance of one balanced and one prepotent set (Mk1: 33 
ensembles and Mk2: 20 ensembles). These 53 ensembles included a total of 1,246 
neurons in the PFC (Mk1: 706 neurons and Mk2: 540 neurons) with an average of 24 
neurons (range 6 – 43) per ensembles and 1,211 neurons in the MD (Mk1: 728 neurons 
and Mk2: 483 neurons) with an average of 23 neurons (range 12 -42) per ensemble. In 
the saline condition, I recorded 43 ensembles (Mk1: 24 ensembles and Mk2: 19 
ensembles) in the PFC and MD simultaneously during performance of a balanced and 
prepotent set. This consisted of a total of 981 PFC neurons (Mk1: 542 neurons and Mk2: 
439 neurons) with an average of 23 neurons (range 14 – 44) per ensemble and 1,057 
MD neurons (Mk1: 595 neurons and Mk2: 462 neurons) with an average of 25 neurons 




3.2A, C and saline: Fig. 3.2B, D) yielded 2 – 6 ensembles (average of 2 ensembles per 
recording day). The naïve dataset, utilized for some comparisons here, is described in 
Chapter 2. 
 
Stimulus encoding across brain areas and drug conditions  
In order to identify neurons that significantly varied their firing rate as a function 
of the cue (A vs. B; during the cue, delay, or probe period), probe (X vs. Y; during the 
probe period), or response (target (T) or nontarget (NT); during the response period), I 
applied ANCOVA (p < 0.05) to neuron firing rates in the drug and saline conditions. In 
both conditions, the MD (Fig. 3.4A, B) and PFC (Fig. 3.3A, B) contained neurons that 
significantly modulated their firing rates depending on the cue (light blue), probe (pink), 
and response (purple). Across the population of sampled neurons in the drug condition, 
57% of PFC neurons and 70% of MD neurons exhibited modulations in firing rate in 
relation to at least one of the task factors. In the saline condition, 66% of PFC neurons 
and 75% of MD neurons exhibited modulations in firing rates in relation to at least one of 
the task factors. Table 3.1 shows the results for all statistical comparisons between the 
proportions of significant neurons observed in each drug condition and area (Z-test 
proportions, p < 0.05). PCP exposure affected the proportion of neurons encoding the 
cue, probe, and response in the PFC and MD variably within each area.  
To determine bias preferences in the drug and saline conditions, I performed a 
one-sample Z-test of proportions (on neurons preferring A vs. B-cue, X vs. Y-probe, T 
vs. NT-response) separated by trial period (cue, delay, probe, and response) in the MD 
(Fig. 3.4 C, D) and PFC (Fig. 3.3C, D). In the PFC during PCP exposure (Fig. 3.3C), 




only significant biases present, as there was no significant bias in delay cue (Z = 1.5607 
p = 0.12), probe (Z = 0.3312 p = 0.74), or response (resp Z = 0.0519 p = 0.96) neurons. 
In the saline condition (Fig. 3.3D), PFC neurons in all groups were biased towards valid 
stimuli that indicated a target response (A-cue: early – Z = 4.1697 p < 0.001, delay – Z = 
13.9975 p < 0.001, and late – Z = 8.3753 p < 0.001; and X-probe: 5.6845 p < 0.001; T-
response: Z = 2.6510 p < 0.01). These biases are opposite to trends observed in the 
naïve data (Fig. 2.3C). In the MD during PCP exposure (Fig. 3.4C) neurons encoding the 
cue in the cue period and in the delay period were biased to prefer the B-cue (early – Z 
= -4.4887 p < 0.001; delay – Z = -3.1021 p < 0.01) and neurons encoding the response 
were biased to prefer the NT response (Z = -2.9733 p < 0.01). There were no significant 
biases in the late cue (Z = 0.2551 p = 0.80) or probe neuron (Z = 0.7576 p = 0.45) 
populations. In the saline condition, MD neurons (Fig. 3.4D) were biased to prefer the B-
cue in the cue period (Z = -3.3796 p < 0.001) and delay period (Z = -4.9573 p < 0.001), 
the A-cue in the probe period (Z = 2.1489 p < 0.05), and X-probe in the probe period (Z 
= 2.4711 p < 0.05). There was no bias in the response neuron population (Z = 1.8189 p 
= 0.07).  
 
Individual neuron activity patterns during the DPX task in drug and saline conditions 
Next, I plotted rasters and individual spike density functions (SDFs), separated 
by trial type in the PFC (Fig. 3.5) and the MD (Fig. 3.6) to examine the influence of drug 
condition on single neuron activity patterns. I found that activity patterns reflecting 
combinations of stimulus and response preferences at different times in the trial that 
were present in the naïve condition, were also present in the drug and saline conditions. 




cue preference from B-cue early to A-cue late in the trial persisted in the drug (PFC: Fig. 
3.5B; MD: Fig. 3.6A) as well as the saline (PFC: Fig. 3.5C; MD: Fig. 3.6C) conditions. 
Also, individual neurons in both drug and saline conditions encoded multiple (PFC: Fig 
3.5A; MD: Fig. 3.6B. D) or single (PFC: Fig. 3.5D) task factors. Therefore, I was able to 
demonstrate that individual neurons recorded during the drug condition modulated their 
activity in much the same manner as neurons in the saline and naïve conditions. 
Therefore, NMDAR blockade did not globally suppress task-related activity in either 
brain area. 
 
Population neural activity patterns during DPX task performance in drug and saline 
conditions 
Neurons were assigned to one of the seven, non-overlapping functional groups 
based on task factor preferences and trial periods that resulted in the modulation of 
neural activity (Chapter 2). Generally, basic functional categories of neural response 
during DPX performance were found to persist in all three drug conditions (naïve, saline, 
and drug) corresponding to three non-overlapping neural samples, both in PFC (Fig. 3.7, 
2.6) and MD (Fig. 3.8, 2.6). This indicates that the various types of modulation of 
neuronal firing rate throughout the trial that were present in the control data were robust 
to NMDAR blockade. Group 1 in MD (Fig. 3.8A, H; Fig. 2.6A) and PFC (Fig. 3.7A, H; Fig. 
2.6H) exhibited a decrease in activity during the cue period on B-cue trials. Group 2 
neurons in MD (Fig. 3.8B, I; Fig. 2.6B) and PFC (Fig. 3.7B, I; Fig. 2.6I) exhibited a switch 
in cue preference from B-cue in the cue period to AY trials in the probe period. Group 3 
neurons in MD (Fig. 3.8C, J; Fig. 2.6C) and PFC (Fig. 3.7C, J; Fig. 2.6J), firing rate was 




cue trials. Group 4 neurons in MD (Fig. 3.8D, K; Fig. 2.6D) and PFC (Fig. 3.7D, K; Fig. 
2.6K) exhibited persistently elevated activity during the delay period selectively on B-cue 
trials. Group 5 neurons in MD (Fig. 3.8E, L; Fig. 2.6E) and PFC (Fig. 3.7E, L; Fig. 2.6L) 
exhibited increased firing rate on X-probe trials that was better aligned to the response 
time (Fig. 3.7, 3.8, 2.6; right panels) than probe onset (left panels). Group 6 and 7 
neurons in MD (Fig. 3.8F, G, M, N; Fig. 2.6F, G) and PFC (Fig. 3.7F, G, M, N; Fig. 2.6M, 
N) exhibited increased activity for target trials around the response time. The only 
apparent differences in population activity firing patterns attributable to the drug 
condition were the blunting of the neural response to the B-cue during the cue period in 
PFC (Group 2; compare Fig. 3.7C to 3.7J and 2.6J) and the loss of AY-selective activity 
in the probe period in MD (Group 3; compare Fig. 3.8B to 3.8I and 2.6I). 
  
Quantification of the population of switch neurons in drug and saline conditions 
To determine if the number of ‘switch neurons’ was affected by NMDA receptor 
blockade, I computed cue preference indices that captured the switching in cue 
preference between cue and probe periods and compared the numbers of neurons with 
significant switch indices in the drug and saline conditions. As I saw in the naive 
condition (Fig. 2.7), there were significantly more neurons that encoded cognitive control 
load (early B-cue to late A-cue preference) than neurons that switched in the opposite 
direction (early A-cue to late B-cue preference) in the drug (PFC: Fig 3.9A, 42 neurons 
compared to 9 neurons, Z = 5.3629 and p < 0.001; MD: 3.9C, 60 neurons compared to 
26 neurons, Z = 4.3409 and p< 0.001) and saline (PFC: Fig 3.9B, 30 neurons compared 
to 1 neuron, Z = 6.0143 and p< 0.001; MD: D, 37 neurons compared to 17 neurons, Z = 




number of cognitive control neurons in the PFC (X2 = 2.3683 p = 0.30601) or MD (X2 = 
0.7 p = 0.7). Additionally, there was no significant difference in the proportion of 
cognitive control neurons between the MD and PFC in the drug (Z = -0.3807 p = 
0.70394) or saline (Z = -1.2758 p = 0.20054) conditions. Therefore, the number of switch 
neurons in each brain region and their relative distribution was not affected by NMDA 
receptor blockade.  
 
Condition effects on the influence of cognitive control load on switch neuron activity  
To investigate if NMDAR blockade influenced the modulation of neural activity by 
cognitive control load, I contrasted neural activity on balanced and prepotent trials in 
each of the drug conditions. Prepotent sets represent higher cognitive control load than 
balanced because the target AX trial type occurs 69% of the time creating a habitual 
response to the A-cue and X-probe that doesn’t exist in balanced sets where all trials are 
presented equally. This habitual response requires an increase in cognitive control 
strength to override it. During the cue period, the B-cue is associated with high cognitive 
control load because it represents an impending need to countermand the target 
response, regardless of the probe identity. In the probe period, the Y- probe that follows 
an A-cue is associated with high cognitive control load because it instructs the inhibition 
of the habitual response to the previously presented A-cue. I computed the difference in 
firing rates of neurons in Groups 2 and 3 (the switch neurons that encode cognitive 
control state per Chapter 2) between the B-cue trials and A-cue trials during the cue 
period and between AY trials and AX trials during the probe period. I then compared 
these differences across trial set types. In general, neural signals that reflected cognitive 




conditions of greater cognitive control demand (prepotent relative to balanced trial sets) 
in the PFC (Fig. 3.10) and MD (Fig. 3.11), both under saline and drug conditions (p < 
0.05; permutation test). Therefore, NMDAR blockade did not strongly influence the effect 
of cognitive control load on neural activity. 
 
Effects of PCP on the timing and strength of single neuron recruitment in MD and PFC. 
To determine the effects of PCP on the timing and strength of cue, probe, and 
response neural signals in the MD and PFC, I compared the time to peak and magnitude 
of proportion explainable variance (PEV) attributable to the cue, probe and response. 
Heat maps show PEV values associated with each predictor variable as a function of 
time, with neurons ordered according to the time of their peak significant regression 
coefficient. PFC and MD neural populations recorded in drug (Fig. 3.12A-C and Fig. 
3.13A-C; left panels) and saline (right panels) conditions exhibited a sequential 
recruitment of neurons throughout the trial period as indicated by the diagonal band of 
warmer color in the heat maps. This demonstrates that the drug did not prevent the 
network from generating a temporally dynamic population code wherein neurons 
modulate their firing rate in relation to task variable for a short period of time at 
staggered times of onset. I also found that PCP did not affect the ability of neurons to 
exhibit persistent activity outside of their peak PEV time point, illustrated by the more 
extended period of firing rate modulation present in the heat maps (longer horizontal 
bands of color in the heat map for the cue and response).  
To determine if PCP affected the timing of neural recruitment within the MD and 
PFC, either chronically or acutely, I compared cumulative distributions of the time to 




conditions. I found that the emergence of cue signals in PFC were chronically delayed 
following exposure to PCP as indicated by significantly slower time to onset in saline 
relative to naïve, with no difference between saline and drug (Fig. 3.12D; Drug vs. 
Saline: KS test = 0.05, p = 0.4; Saline vs. Naive: KS test = 0.09, p < 0.01). Response 
signals were similarly chronically delayed (Fig. 3.12F Drug vs. Saline: KS test = 0.08, p = 
0.21; Naive vs. Saline: KS test = 0.12, p < 0.05). NMDAR blockade delayed probe 
signals acutely (Fig. 3.12E; Drug vs. Saline: KS test = 0.13, p < 0.001) but not 
chronically (Naive vs. Saline: KS test = 0.06, p =0.54). In the MD, cue (Fig. 3.13G; Drug 
vs. Saline: KS test = 0.07, p < 0.05; Naive vs. Saline: KS test = 0.07, p < 0.05), probe 
(Fig. 3.13H; Drug vs. Saline: KS test = 0.15, p < 0.001; Naive vs. Saline: KS test = 0.02, 
p =1), and response (Fig. 3.13I; Drug vs. Saline: KS test = 0.011, p < 0.01; Predrug vs. 
Saline: KS test = 0.09, p < 0.01) signals were all delayed acutely and chronically 
following PCP exposure. 
To characterize the effect of PCP exposure on the strength of neural recruitment 
within the MD and PFC, I computed the population average PEV time course for each 
condition and task variable. I then evaluated the significance of differences between 
drug and saline conditions to examine acute drug effects and between naïve and saline 
conditions to examine chronic drug effects (p < 0.05; permutation test). In the PFC, the 
population average PEV attributable to the cue was acutely decreased in the drug 
condition, during the cue period and the probe period (Fig. 3.12G). Population average 
PEV attributable to the probe was higher at the end of the trial in the drug condition 
compared to the saline condition (Fig. 3.12H). Lastly, population average response PEV 
in the drug condition was reduced relative to saline and naïve conditions at different 




average PEV attributable to the cue was acutely decreased in the drug condition relative 
to saline during the cue period and the probe period (Fig. 3.13G). Probe (Fig. 3.13H) and 
response (Fig. 3.13I) PEV were reduced around the time of the response and increased 
later in the intertrial interval. 
 
NMDAR blockade reduces population encoding of the cue, probe and response in the 
PFC and MD  
To further examine the chronic and acute effects of PCP exposure on the 
strength and timing of neural signals within the MD and PFC, I conducted a time-
resolved decoding analysis. This quantified the information about task variables encoded 
by patterns of neural activity. Following the decoding analysis, I calculated significant 
differences in the decoding results between the drug and saline (acute effects) 
conditions and naive and saline (chronic effects) conditions obtained from MD and PFC. 
In the PFC, cue signals were chronically reduced in the saline relative to the naïve drug 
condition (Fig. 3.14A, left panel), a pattern that was particularly prominent on B-cue trials 
(Fig. 3.14A, right). In the drug condition, the decoder reached ceiling and nearly always 
decoded neural activity to the A-cue (Fig. 3.14A, left and middle panels), reflecting the 
much weaker B-cue representation (Fig. 3.14A, right panel). This was generally true for 
probe representation in the drug condition as well, and the decoder reached ceiling and 
nearly always decoded neural activity to the X-probe (Fig. 3.14B, left and middle panels), 
reflecting the weaker Y-probe representation relative to saline (Fig. 3.14B, right). Y-
probe representation was significantly weaker in saline relative to naïve indicating a 
chronic effect (Fig. 3.14B, right). Response decoding exhibited a similar pattern, with the 




representation of nontarget trials in the drug condition and exhibiting chronic decreased 
in nontarget representation in the saline relative to naïve data (Fig. 3.14C). Overall, 
during acute PCP exposure PFC neurons mostly represented information about the valid 
stimuli and responses (A, X, and T), indicating the loss of neural signals encoding invalid 
stimuli and responses (B, Y, NT). Finally, there was evidence that repeated PCP 
exposure chronically reduced representation of invalid stimuli and responses. In the MD, 
there was a much stronger residual B-cue representation in the presence of NMDAR 
receptor blockade (Fig. 3.15A, right; red) in comparison to the near total elimination of 
the B-cue representation in prefrontal cortex (Fig. 3.14A, right). Consequently, the 
decoder did not peg at ceiling. In addition, the neural representation of valid stimuli and 
responses was chronically reduced for cue, probe and response signals (Fig. 3.15A-C, 
middle panels). Finally, B-cue signals were chronically reduced during the probe period 
(Fig. 3.15A, right). Overall, NMDAR blockade affected the neural representation of task 
stimuli much less in MD than that in the PFC.  
To determine if the weak B-cue representation in the PFC in the drug condition 
reflected the greater number of errors committed on B-cue trials or the fact that I used 
only neural data on correct trials to train the decoder, I reran the analysis using both 
correct and error trials in the training data. Inclusion of errors in the training data 
marginally increased the strength of the signal (posterior probability) in the PFC coding 
the B-cue (Fig. 3.16A) but decoding still did not approach the level achieved in the naïve 
or saline conditions (Fig. 3.14A, right). This indicates that the decrease in B-cue 
decoding was not attributable to the fewer number of correct trials or the increased 
number of errors only. In the MD, inclusion of error trials in the training data modestly 




Including error trials into the training data did not modify Y-probe or NT-response 
posterior probabilities in the PFC or the MD (Fig. 3.16C-F). 
 
Changes in population activity predict errors in the drug condition 
To determine if trial outcome was represented in the MD or PFC during the drug 
condition, I conducted time-resolved pattern classification on BX trials only, using an 
equal number of error and correct trials in the analysis. Overall the MD contained a 
stronger representation of the outcome of the trial (error or correct) in the cue period and 
probe period (Fig. 3.17, blue), while neural activity in the PFC bore a weaker relation to 
trial outcome (red). This indicates that the MD contained reliably different patterns of 
activity on error trials versus correct trials, potentially reflecting its stronger 
representation of the response (and hence outcome).  
 
Effects of PCP on functional coupling between neurons coding the cue, probe and 
response within the same brain area. 
To determine if PCP exposure resulted in acute or chronic effects on information 
transmission within local PFC and MD circuits during DPX task performance, I applied a 
signal transmission analysis (Crowe et al., 2013b). This analysis measures correlations 
in temporal fluctuations related to the amount of information encoded by different groups 
of simultaneously recorded neurons (see Methods). In the PFC under the saline 
condition, cue neurons transmitted significant information to probe and response 
neurons during the cue period (Fig. 3.18B, D; light blue circles), which was absent in the 
drug condition (Fig. 3.18A, C; light blue, note lack of significant transmission during cue 




neurons (Fig. 3.18C, D; purple) to cue neurons persisted in the drug condition relative to 
the saline and in some cases was enhanced (Fig. 3.18C). Transmission of information 
between probe and response neurons was comparable across conditions (Fig. 3.18E, 
F). Transmission of information from cue to probe and response neurons in the saline 
condition (Fig. 3.18B, D; blue) was chronically reduced relative to the naïve condition 
(Fig. 2.12A, C; blue). In the MD, acute PCP exposure reduced signal transmission from 
cue to probe neurons in the cue period (Fig. 3.19A, B; blue), while cue to response 
signal transmission was stronger in the drug condition during the probe period (Fig. 
3.19C, D; blue). As in the PFC, there was little effect of drug on probe and response 
signal transmission (Fig. 3.19E, F). Overall, signal transmission in the PFC and the MD 
indicated that transmission of information between cue, probe, and response neurons 
that would be needed to mediate logical operations for cognitive control was reduced 
following NMDA receptor blockade.  
 
Effects of PCP on functional coupling between neurons in MD and PFC.  
To determine the effect of NMDAR blockade on thalamocortical network 
communication during cognitive control, I measured signal transmission between the MD 
and PFC in neurons encoding the same task variable. In the saline condition, I found 
evidence of robust top-down transmission (red) of information from PFC to MD involving 
neurons encoding the probe and response, that occurred during the late delay and probe 
periods (Fig. 3.20D, F), which was largely abolished in the drug condition (Fig. 3.20C, 
E). Instead, the drug condition was associated with the emergence of both top-down and 
bottom-up transmission between cue, probe, and response neurons that occurred later 




during the cue period between cue and response neurons was chronically reduced in the 
saline condition (Fig. 3.20B, F) compared to the naïve condition (Fig. 2.13A, C). This 
indicates a selective loss of information transmission across the MD and PFC during the 
cue period when neurons encoding the cue (and hence task state) would normally 
interact with other neurons in the circuit. This could lead to a failure to encode cue-
instructed context and communicate this information between MD and PFC, leading to 
the inability to inhibit a prepotent response based on contextual information (BX error). 
 
DISCUSSION 
Thalamocortical dysfunction has been implicated in patients with SZ, with 
different patterns of deficits found in sensory relay thalamocortical networks, which 
exhibit increased functional coupling and activity in patients and association 
thalamocortical networks, which exhibit the reverse. The MD thalamic nucleus provides 
the primary thalamic input to the prefrontal cortex (PFC), and it receives reciprocal input 
from PFC in return (Goldman-Rakic and Porrino, 1985; Preuss and Goldman-Rakic, 
1987; Xiao et al., 2009). Functional connectivity in fMRI (Woodward et al., 2012; 
Anticevic et al., 2014b; Anticevic et al., 2014a; Tu et al., 2015) and anatomical 
connectivity evaluated with diffusion tensor imaging (Giraldo-Chica et al., 2018) provide 
evidence that communication between the MD and PFC is decreased in the disease. 
Additionally, both the PFC and the MD exhibit decreased activation in fMRI studies of 
patients performing a gamut of cognitive control tasks (Minzenberg et al., 2009). 
Although the above data point to dysfunctional dynamics within the MD-PFC network, 
they do not provide information about network failure at the cellular level. To better 




relate it to the neural pathophysiology of SZ, I recorded from monkeys in both areas 
simultaneously following an injection of PCP (a potent NMDA receptor antagonist) during 
performance of a cognitive control task translated from patients with SZ. PCP exposure 
in monkeys reliably produces an error pattern (increased ‘BX’ errors) in cognitive control 
that is found in patients with SZ performing the same DPX task (Blackman et al., 2013). 
My results show NMDAR blockade produced distinct effects on neurons in the MD 
relative to the PFC, both acutely and chronically. I found that blocking NMDAR synaptic 
transmission systemically: (1) both acutely and chronically reduced the strength and 
prevalence of neural signals encoding task state (‘countermand probability’) both at the 
single neuron and population levels, (2) more strongly degraded state signals in the PFC 
than the MD, (3) delayed the emergence of task-related signals in both structures, (4) 
increased the occurrence of BX errors that were better predicted by changes in neural 
activity in the MD than the PFC, and (5) disrupted the pattern of information transmission 
between neurons in local circuits within each structure as well as transmission of 
information between the MD and PFC.  
 
State signals  
Task-related signals in the MD-PFC circuit can be broadly classified as encoding 
task ‘state’ and the behavioral response. ‘State’ neurons exhibited a switch in their 
preference for the identity of visual stimuli appearing during the cue and probe periods in 
the trial which instructed the nontarget, counter-habitual response (B-cues during the 
cue period, AY cue-probe sequence during the probe period). The activity of these 
neurons is not time-locked to the motor response (Fig. 3.7, 3.8), but rather appears to 




stimuli. I found that following NMDAR blockade, neurons that encode task state were 
differentially affected in the MD and the PFC. In the PFC, little residual representation of 
B-cues and Y-probes persisted following NMDAR blockade (Fig. 3.14A, right) whereas in 
the MD, the B-cue and Y-probe signals were largely intact (Fig. 3.15A, right). This 
suggests that circuits in the MD and PFC are differentially sensitive to NMDAR synaptic 
failure. Moreover, at the single neuron level, effects of NMDAR blockade on state 
neurons in the PFC and MD appeared comparable (as indicated by approximately 
equivalent reductions in cue PEV in the two structures, for example; Figs. 3.12G, 
3.13G). This suggests that the neural representation at the population level is more 
adversely affected by NMDAR blockade in the PFC than the MD. One such aspect of 
population encoding that could contribute to the reduction in population decoding is an 
increase in noise correlation between neurons, suggesting a potential role for decreased 
attention following NMDAR blockade in the production of BX errors (Cohen and 
Maunsell, 2009). The population representation of state appeared to use a temporally 
dynamic code (in which individual neurons carried signal for brief periods at staggered 
times of onset). Blocking NMDAR modestly delayed the dynamic recruitment of state 
signals (as instructed by the cue and probe) both in PFC (Fig. 3.12) and MD (Fig. 3.13). 
One key question is what change in neural activity contributes to the elevation of BX 
errors seen in the drug condition. I found that changes in state representation (as 
encoded by Group 2 and 3 neurons) predicted BX errors on a trial-by-trial basis and that 
state signals in MD predicted errors better than state signals in PFC (Fig. 3.17). This is 
consistent with our other evidence that MD neurons are preferentially engaged to 
encode the response (as described in Chapter 2). The disruption of task-related activity 




activity found in the baseline data persisted in the drug condition. For example, state 
neurons in the MD and PFC both continued to exhibit the ‘switch’ pattern of activity 
which was accentuated under conditions of increased cognitive control load in the drug 
condition (Fig. 3.9, 3.10 and 3.11).  
 
Response signals  
 Interestingly, NMDAR blockade did not seem to affect signals encoding the 
motor response in the MD as strongly as in the PFC, even though the MD contains more 
overall response related signals than the PFC, at baseline (Chapter 2). For example, 
population representation of nontarget response information was significantly weaker in 
the PFC following NMDAR blockade (Fig. 3.14), while nontarget response 
representation in the MD remained relatively unaffected (Fig. 3.15). This is consistent 
with the selective degradation of state signals in the PFC encoding the counter-habitual 
response compared to the MD (discussed above). 
 
Effects of NMDAR blockade on neural communication 
The DPX task requires that the brain perform a logical operation to compute the 
correct response based on combinations of stimuli shown (e.g. if A-cue and X-probe 
then target response). This is likely to involve physiological interaction between groups 
of neurons encoding all three variables (cue, probe, and response). Evidence of 
interactions was found both within and between the MD and the PFC in the naïve 
condition (Chapter 2). I found that acute exposure to PCP modulated the flow of 
information between neurons encoding task variables in local circuits both with the MD 




perform logical operations that require combining cue and probe information to compute 
the conditional response. Transmission of information about the state and response in 
the MD-PFC thalamocortical network was diminished following PCP exposure. Top-
down transmission of probe and response information during the delay and probe 
periods from PFC to MD was essentially abolished by acute PCP exposure (Fig. 3.20). 
Both top-down and bottom-up transmission of cue and response information during the 
cue period was chronically reduced (Fig. 3.20 compared to Fig. 2.13). These data 
suggest that NMDAR, in addition to influencing synaptic plasticity over longer time 
scales, play a direct role in neuronal communication for computations supporting 
cognitive control. 
 
Relation to prior work in animal models  
To our knowledge, there are no prior experiments that have recorded in the 
primate MD following administration of an NMDAR antagonist. Prior studies recording 
the monkey PFC following the administration of an NDMAR antagonist have 
demonstrated a decrease in the strength of task related neural signals, including delay 
period activity associated with working memory (Wang et al., 2013), as well as neural 
signals encoding rules and feedback in a delayed anti-saccade task (Skoblenick and 
Everling, 2012; Ma et al., 2015) and action monitoring (Skoblenick and Everling, 2014). 
Still, these studies did not address changes in neural activity and dynamics related to the 
performance on a cognitive control task translated from patients or investigate 
thalamocortical networks dynamics in the MD and PFC that may underlie the behavioral 




In the rodent, studies have examined the influence of NMDAR blockade on MD-
PFC activation and dynamics during spatial working memory performance 
(Kupferschmidt and Gordon, 2018). Acute systemic administration of NMDAR 
antagonists (Ketamine or PCP) produced mixed effects on the firing rate of MD and 
mPFC neurons (Celada et al., 2013; Furth et al., 2017), as well as increased gamma 
power LFP oscillations in MD and mPFC in rats (Furth et al., 2017). Injection of the 
NMDAR antagonist MK 801 into the rat MD increased delta power in mPFC (Kiss et al., 
2011). These studies show that MD-PFC dynamics are modified by NMDAR blockade in 
rats, but do not relate these changes in neural function to altered cognitive control 
performance. In addition, I found little evidence that PCP altered firing rates of task-
related neurons (Figs. 3.7, 3.8) suggesting that differences in the influence of NMDAR 
synaptic function on the MD-PFC network may differ between species. 
 
Relation to schizophrenia  
Functional imaging studies in SZ have repeatedly shown reduced PFC activation 
in patients specifically related to the neural representation of B-cues performance in the 
DPX task and its analogous task the AX-Continuous Processing Task (Barch et al., 
2001; Perlstein et al., 2003; Yoon et al., 2008; Lesh et al., 2013; Poppe et al., 2016). 
Patients with SZ further exhibit a decrease in the activation of the MD during cognitive 
control performance (Minzenberg et al., 2009), as well as reduced MD-PFC 
thalamocortical functional connectivity at rest (Welsh et al., 2010; Woodward et al., 
2012; Anticevic et al., 2014b; Anticevic et al., 2014a; Tu et al., 2015). Several aspects of 
these results have parallels in my current data. The reduction of B-cue activation in PFC 




state encoding generally, that I observed in monkey PFC following NMDAR blockade. A 
recent report used diffusion tensor imaging (DTI) to measure white matter tract integrity 
between PFC and MD and relate it to behavioral performance in patients with 
schizophrenia performing a variety of executive function tasks, including the AX-CPT 
(Giraldo-Chica et al., 2018). This study found that decreased thalamocortical anatomical 
connectivity, specifically from the MD to the PFC, was correlated with poorer working 
memory performance but not with poorer performance on the AX-CPT. My data suggest 
that functional communication between MD and PFC is disrupted by NMDAR synaptic 
malfunction. This may mean that even though anatomical connectivity from the MD and 
PFC is not related to context processing in the AX-CPT, information flow between the 
two areas could still be dysfunctional due to other factors, including NMDA receptor 
hypofunction. Generally, my data are consistent with the characterization of SZ as a 
functional ‘disconnection’ syndrome (Friston, 1998; Stephan et al., 2006) that results in 
altered patterns of information flow in prefrontal networks (Woodward et al., 2012).  
 
Conclusions  
Our data are unique in that they provide cell and circuit level information about 
the distributed processing of task state information across the MD and PFC during 
NDMAR disruption that underlies cognitive deficits in a pharmacological model of SZ. I 
provide evidence of decreased population encoding and functional connectivity in the 
MD-PFC thalamocortical network, specifically related to the neural representation of 
state that is required for correct response selection. State representation in PFC was 
preferentially degraded by NMDAR blockade relative to MD. This suggests that loss of 




errors in patients. Conversely, the motor response and trial outcome (e.g. errors) under 
NMDAR blockade, were better represented in MD, suggesting this structure plays a 
more direct role in response selection and execution. Lack of state signal input to MD 
may therefore result in excessive influence of habitual response signal input from the 
basal ganglia (Haber and McFarland, 2001; Weickert et al., 2002; Yin and Knowlton, 
2006), leading to commission of BX errors. However, future experiments will need to be 
done to determine the effect of NMDAR on basal ganglia input to the MD during 
cognitive control performance. In patients with SZ it was recently shown that 
improvement in cognitive control performance using cognitive behavioral therapy was 
correlated with an improvement in thalamocortical functional connectivity (Ramsay et al., 
2017). This is further confirmation of the need to understand the nature of MD-PFC 
connectivity underlying cognitive control deficits for future therapeutic developments 















TABLES AND FIGURES 
 
Table 3.1. Statistical results comparing proportions of significant neurons across 
conditions and brain regions. Bolded results indicate significant differences via z-test 














Naive Vs. Saline 
Z = 2.73 
p < 0.01 
Z = 15.66 
p < 0.01 
Z = 0.49 
p = 0.62 
Z = 0.99 
p = 0.32 
PFC 
Saline Vs. Drug 
Z = 4.06 
p < 0.001 
Z = 1.55 
p = 0.12 
Z = 3.72 
p < 0.001 
Z = -2.34 
p < 0.05 
MD 
Naive Vs. Saline 
Z = 5.27 
p < 0.001 
Z = 0.63 
p = 0.53 
Z = 2.69 
p < 0.01 
Z = 3.34 
p < 0.001 
MD 
Saline vs. Drug 
Z = 3.11 
p < 0.01 
Z = 3.42 
p < 0.001 
Z = -0.60 
p = 0.55 
Z = 0.83 
p = 0.41 
PFC vs. MD 
Drug 
Z = -6.29 
p < 0.001 
Z = -2.50 
p < 0.05 
Z = -6.30 
p < 0.001 
Z = -1.52 
p = 0.11 
PFC vs. MD 
Saline 
Z = 21.58 
p < 0.001 
Z = 0.26 
p = 0.79 
Z = -1.82 
p = 0.069 
Z = -4.68 





Figure 3.1. Behavioral performance in NMDA receptor blockade and saline 
conditions. Mean (±2 standard error of the mean, SEM) proportion of trials correct (A.) 
and reaction time (B.) in seconds is shown split by trial (cue-probe sequence) and by 
monkey (Mk 1- dashed lines and open circles; Mk 2- solid lines and closed circles; Drug 










Figure 3.2. Reconstructions of electrode array recording sites. Two-dimensional 
(2D) reconstructions of chamber and grid locations (red dots indicate recording sites) 
superimposed on a dorsal view of sulcal anatomy in Mk1 (A, B) and Mk 2 (C, D) for the 
drug (A, C) and saline (B, D) conditions. Yellow region indicates relative location of the 
MD superimposed on the sulcal anatomy. MD: Mediodorsal nucleus of the thalamus, PS: 






Figure 3.3. Numbers of neurons selective for cue, probe and response in the PFC 
during NMDA receptor blockade and saline conditions. A, B. Venn diagrams depict 
the numbers of neurons exhibiting significant selectivity (ANCOVA, p < 0.05) for the cue 
(blue), probe (pink), and/or response (purple) in drug (A) and saline (B) conditions. Area 
of circles is proportional to neuron number. C, D. Bars indicate the number of neurons in 
the drug (C) and saline (D) conditions that exhibit preference for specific cues (A or B), 
probes (X or Y), and responses (T or N). Asterisks indicate significant biases in 
preference for specific cue, probes, and responses in the neural population (One sample 







Figure 3.4. Numbers of neurons selective for cue, probe and response in the MD 
during NMDA receptor blockade and saline conditions. A, B. Venn diagrams depict 
the numbers of neurons exhibiting significant selectivity (ANCOVA, p < 0.05) for the cue 
(blue), probe (pink), and/or response (purple) in drug (A) and saline (B) conditions. Area 
of circles is proportional to neuron number. C, D. Bars indicate the number of neurons in 
the drug (C) and saline (D) conditions that exhibit preference for specific cues (A or B), 
probes (X or Y), and responses (T or N). Asterisks indicate significant biases in 
preference for specific cue, probes, and responses in the neural population (One sample 







Figure 3.5. Single neuron activity during DPX task performance in the PFC during 
NMDA receptor blockade and saline conditions. Each row of panels illustrates the 
activity of a single neuron in drug (A, B) or saline (C, D) conditions. Individual panels 
indicate activity on a single trial type defined by cue-probe sequence. Rasters indicate 
timing of action potentials, spike density functions (solid gray;  = 40 ms; 10 Hz/div) 
show modulations in average firing rate. Red tick marks indicate the time of the 




injection: PFC cell 6621 is an example of a neuron whose firing rate during the cue 
period is greater on B-cue trials than A-cue trials and activity in the probe period is 
greater on Y-probe trials than X-probe trials. B. Early B-cue and Late A-cue neuron 
recorded following a PCP injection. PFC cell 7081 is an example of a ‘switch’ neuron 
that switches its cue preference from B-cues during the cue period to A-cues during the 
probe period. C. Early B-cue and Late AY-trial neuron recorded following a saline 
injection: PFC cell 8368 is an example of a neuron whose firing rate is greater on B-cue 
than A-cue trials during the cue period and is greater on AY trials in the probe period. D. 
X-probe neuron recorded following a saline injection: PFC cell 4111 is an example of a 



















Figure 3.6. Single neuron activity during DPX task performance in the MD during 
NMDA receptor blockade and saline conditions. Each row of panels illustrates the 
activity of a single neuron in drug (A, B) or saline (C, D) conditions. Individual panels 
indicate activity on a single trial type defined by cue-probe sequence. Rasters indicate 
timing of action potentials, spike density functions (solid gray;  = 40 ms; 10 Hz/div) 
show modulations in average firing rate. Red tick marks indicate the time of the 




injection. MD cell 8122 is an example of a ‘switch’ neuron that switches its cue 
preference from B-cues during the cue period to A-cues during the probe period. B. 
Early B-cue and Y-probe neuron recorded following a PCP injection: MD cell 8250 is an 
example of a neuron whose firing rate during the cue period is greater on B-cue trials 
than A-cue trials and activity in the probe period is greater on Y-probe trials than X-probe 
trials. C. Early B-cue and Late A-cue neuron recorded following a saline injection. MD 
cell 4197 is an example of a ‘switch’ neuron that switches its cue preference from B-cues 
during the cue period to A-cues during the probe period. D. Early B-cue and Y-probe 
neuron recorded following a saline injection: MD cell 7009 is an example of a neuron 
whose firing rate during the cue period is greater on B-cue trials than A-cue trials and 
















Figure 3.7. Population activity patterns in functionally defined neural groups in 
prepotent trial sets in the PFC during NMDA receptor blockade and saline 




population activity patterns on subsets of trials defined by cue-probe sequence (AX: 
orange, AY: red, BX: purple, BY: blue). Neurons were divided into seven non-
overlapping functional groups (see Results text) depending on the specific preference for 
individual cues, probes, and responses as well as the trial period that neurons exhibited 
selective activity as defined by ANCOVA. Population activity of neurons recorded in drug 
(A - G) and saline (H - N) conditions is shown aligned to cue onset (left panels) and time 






















Figure 3.8. Population activity patterns in functionally defined neural groups in 
prepotent trial sets in the MD during NMDA receptor blockade and saline 




population activity patterns on subsets of trials defined by cue-probe sequence (AX: 
orange, AY: red, BX: purple, BY: blue). Neurons were divided into seven non-
overlapping functional groups (see Results text) depending on the specific preference for 
individual cues, probes, and responses as well as the trial period that neurons exhibited 
selective activity as defined by ANCOVA. Population activity of neurons recorded in drug 
(A - G) and saline (H - N) conditions is shown aligned to cue onset (left panels) and time 

















Figure 3.9. Quantification of switch in cue preference from the cue to the probe 
period in single neurons on prepotent trial sets during NMDA receptor blockade 
and saline conditions. I computed an index quantifying cue preference (B-cue – A-cue) 
/ (B-cue + A-cue) using cue and probe period firing rates for each neuron. A – D. 
Colored symbols indicate neurons with a significant switch from B-cue to A-cue 
preference between the cue and probe periods (red circles) or the opposite switch in 
preference (blue circles). Gray symbols indicate neurons that encoded the cue during 




for PFC neurons recorded following a PCP injection (A) and saline injection (B) and MD 
neurons recorded following a PCP injection (C) and saline injection (D) recorded during 












Figure 3.10. Modulation of cognitive control neural signals with cognitive control 
load in the PFC during NMDA receptor blockade and saline conditions. Blue 
shading indicates difference in cue period firing rates on B-cue and A-cue trials. Pink 
shading indicates difference in probe period firing rates on AY and AX trials. A, B. 




recorded following a PCP injection (C) and saline injection (D) on balanced (left) and 
prepotent (right) trial sets. Asterisks (*) indicate a significant increase in the difference in 
cue period firing rate on B-cue and A-cue trials on prepotent relative to balanced trial 
sets (p < 0.05, permutation test). Pound symbols (#) similarly indicate a significant 
increase in the difference in probe period firing rate on AY and AX trials in prepotent 






Figure 3.11. Modulation of cognitive control neural signals with cognitive control 
load in the MD during NMDA receptor blockade and saline conditions. Blue shading 
indicates difference in cue period firing rates on B-cue and A-cue trials. Pink shading 




activity of Group 2 neurons. C, D. Population activity of Group 3 neurons recorded 
following a PCP injection (C) and saline injection (D) on balanced (left) and prepotent 
(right) trial sets. Asterisks (*) indicate a significant increase in the difference in cue 
period firing rate on B-cue and A-cue trials on prepotent relative to balanced trial sets (p 
< 0.05, permutation test). Pound symbols (#) similarly indicate a significant increase in 
the difference in probe period firing rate on AY and AX trials in prepotent relative to 




















Figure 3.12. Proportion of explained variance (PEV) in firing rate over trials as a 
function of time in the PFC across conditions. A-C. Warmer colors in the heat maps 
represent greater PEV values associated with the cue (A), probe (B), and response (C). 
PEV values were obtained by regressing the firing rate of each neuron onto the 
appropriate task factor over trials within a sliding 100 ms window (advanced in 20 ms 
steps). Drug data is on the left and saline data on the right. D-F. Cumulative distributions 
of time to peak PEV attributable to the cue (D), probe (E), and response (F) in neurons 
recorded in the predrug (gray), drug (red), and saline (blue) conditions. G-I. Population 
average PEV attributable to the cue (G), probe (H), and response (I) neurons recorded 
in the predrug (gray), drug (red), and saline (blue) conditions. Significant differences in 
population average PEV time courses are indicated with circles (gray indicates higher 
population average on predrug compared to saline, blue indicates higher population 




average on saline compared to drug and red indicates higher population average on 


















Figure 3.13. Proportion of explained variance (PEV) in firing rate over trials as a 
function of time in the MD across conditions. A-C. Warmer colors in the heat maps 
represent greater PEV values associated with the cue (A), probe (B), and response (C). 
PEV values were obtained by regressing the firing rate of each neuron onto the 
appropriate task factor over trials within a sliding 100 ms window (advanced in 20 ms 
steps). Drug data is on the left and saline data on the right. D-F. Cumulative distributions 
of time to peak PEV attributable to the cue (D), probe (E), and response (F) in neurons 
recorded in the predrug (gray), drug (red), and saline (blue) conditions. G-I. Population 
average PEV attributable to the cue (G), probe (H), and response (I) neurons recorded 
in the predrug (gray), drug (red), and saline (blue) conditions. Significant differences in 
population average PEV time courses are indicated with circles (gray indicates higher 
population average on predrug compared to saline, blue indicates higher population 




average on saline compared to drug and red indicates higher population average on 









Figure 3.14. Time-resolved population decoding of cue, probe and response PFC 
neurons using all significant neurons across all conditions. Functions plot the 
population average posterior probability associated with the neural representation of the 
cue (A), probe (B), and response (C) as a function of time in the trial, based on neural 




on prepotent trial sets. Left panels illustrate posterior probability averaged over all trials, 
center and right panels plot posterior probability averaged over the subsets of trials 
indicated above. Horizontal dashed lines indicate chance decoding based on the prior 
probabilities of cue, probe, and response in prepotent trial sets. For example, before the 
cue appeared and neural signals encoding the cue developed, the prior probability if of 
the A-cue was 0.81 (AX and AY trials comprised 81% of trials in prepotent sets). 
Baseline decoding (before cue onset) reflects the prior probability of the decoded task 
variable. Circles and triangles indicate significant differences in decoding strength 
between areas (p < 0.05, predrug > saline in gray circles, saline > predrug in blue 
circles, drug > saline in red triangles, saline > drug in blue triangles, permutation test, 


















Figure 3.15. Time-resolved population decoding of cue, probe and response MD 
neurons using all significant neurons across all conditions. Functions plot the 
population average posterior probability associated with the neural representation of the 




population activity in predrug (gray), drug (red), and saline (blue). Neural data recorded 
on prepotent trial sets. Left panels illustrate posterior probability averaged over all trials, 
center and right panels plot posterior probability averaged over the subsets of trials 
indicated above. Horizontal dashed lines indicate chance decoding based on the prior 
probabilities of cue, probe and response in prepotent trial sets. For example, before the 
cue appeared and neural signals encoding the cue developed, the prior probability if of 
the A-cue was 0.81 (AX and AY trials comprised 81% of trials in prepotent sets). 
Baseline decoding (before cue onset) reflects the prior probability of the decoded task 
variable. Circles and triangles indicate significant differences in decoding strength 
between areas (p < 0.05, predrug > saline in gray circles, saline > predrug in blue 
circles, drug > saline in red triangles, saline > drug in blue triangles, permutation test, 

















Figure 3.16. Time-resolved population decoding of invalid cue, probe and 
response variables on correct and error trials in MD and PFC neurons during 
NMDA receptor blockade. Functions plot the population average posterior probability 
associated with the neural representation of the B-cue (A, B), Y-probe (C, D), and NT-
response (E, F) as a function of time in the trial, based on neural population activity of all 
significant neurons on correct trials (solid lines) and all trials (correct and error, dashed 









Figure 3.17. Time-resolved population decoding of trial outcome with MD and PFC 
neurons during NMDA receptor blockade. Functions plot the population average 
posterior probability associated with the neural representation of the trial outcome 
(correct or error) as a function of time in the trial, based on neural population activity of 
all significant neurons (A), neurons in groups 2 and 3 (B), and neurons in groups 6 and 7 
(C). Neural data recorded on prepotent trial sets on BX trials only and equalized the 
number of trials for trial outcome (15 correct BX trials and 15 error BX trials). Circles 
indicate significant differences in decoding strength between areas (p < 0.05, MD > PFC 









Figure 3.18. Task signal transmission between subsets of neurons within the PFC 
encoding the cue, probe and response in drug and saline conditions. Functions 
illustrate the time course of signal transmission between subsets of neurons located 
within the same brain area that encoded different task variables. The direction of signal 
transmission between neural subsets is indicated by color (see legend above each 
column). Circles indicate time points where the strength of transmission was significantly 
nonzero, defined as time points where the F-statistic exceeded the 95th percentile (FDR 
corrected) of a bootstrap distribution of F-statistics at that time point generated after 
shuffling trials of posterior probability time series to break the simultaneity of the 
underlying neural data and repeating the regression analysis and corrected for multiple 
comparisons. A, C, E. Transmission between subsets of neurons encoding the cue and 
probe (A), cue and response (C), and probe and response (E) following an injection of 





Figure 3.19. Task signal transmission between subsets of neurons within the MD 
encoding the cue, probe and response in drug and saline conditions. Functions 
illustrate the time course of signal transmission between subsets of neurons located 
within the same brain area that encoded different task variables. The direction of signal 
transmission between neural subsets is indicated by color (see legend above each 
column). Circles indicate time points where the strength of transmission was significantly 
nonzero, defined as time points where the F-statistic exceeded the 95th percentile (FDR 
corrected) of a bootstrap distribution of F-statistics at that time point generated after 
shuffling trials of posterior probability time series to break the simultaneity of the 
underlying neural data and repeating the regression analysis and corrected for multiple 
comparisons. A, C, E. Transmission between subsets of neurons encoding the cue and 
probe (A), cue and response (C), and probe and response (E) following an injection of 





Figure 3.20. Signal transmission between PFC and MD neurons encoding the 
same task variable in the drug and saline injections. Functions plot is the time 
course of transmission of (A, B) cue, (C, D) probe, and (E, F) response signals between 
neurons in the MD and PFC. Top-down (PFC to MD) transmission in red and bottom-up 
(MD to PFC) in blue. Transmission between neurons recorded following an injection of 
drug (A, C, E) or saline (B, D, F). Signal transmission is indicated by circles, where 
regressions were significantly above the bootstrap regressions (p < 0.05; permutation 













My dissertation work is the first characterization of the distributed processing 
underlying cognitive control of simultaneously recorded neural activity in the mediodorsal 
nucleus of the thalamus (MD) and prefrontal cortex (PFC), both in the healthy state and 
a Schizophrenia (SZ) -like state. The MD has been implicated as a partner of the PFC in 
cognitive control due to MD’s reciprocal anatomical connections with the PFC, the 
findings that MD neurons exhibit similar activity patterns to their PFC counterparts during 
cognitive behaviors, and the fact that lesions of the MD nucleus or inhibition of MD 
neurons result in PFC-like deficits in cognition. Additionally, the MD and PFC have both 
been found to be dysfunctional in patients with SZ, including decreased functional 
connectivity between the two. In order to increase the translatability of my research in an 
animal model of the human disorder, I trained monkeys to perform the exact cognitive 
control task given to SZ patients, the dot pattern expectancy task (DPX). First, I 
characterized thalamocortical distributed processes and functional coupling arising from 
cellular activity of simultaneously recorded neurons in the MD and PFC in the healthy 
state. Then, I related underlying neural pathophysiology of the MD and PFC to the 
impaired performance on the DPX task caused by NMDA receptor (NMDAR) blockade. I 
provide the first evidence that neurons in the MD represent cognitive control state similar 
to PFC neurons and that neurons in the MD and PFC transmit this state information 
reciprocally during cognitive control performance. Further, I provide the first description 




cognitive state in the MD and PFC and a loss of functional information transmission 
between the MD and PFC. These findings support the hypotheses that the neurons in 
the MD participate in cognitive control behaviors and that thalamocortical, specifically 
between the MD and the PFC, functional disconnection underlies cognitive deficits in 
patients with SZ.  
 
Summary of findings 
In Chapter 2, I describe distributed neural signals in the MD and PFC that 
underlie cognitive control as measured by the dot-pattern expectancy task (DPX). The 
DPX task requires a logical operation based on a cue stimulus that provides the context 
for the subsequent probe stimulus, which are separate by a delay. Once the probe is 
presented, a response must be made based on the combination of the cue and probe 
stimuli (i.e. if A-cue and X-probe, then target response). I report that the MD contained 
‘switch’ neurons that encoded task state in a similar manner as PFC ‘switch’ neurons. 
These neurons are considered state neurons as they modulate their firing rate during 
scenarios when the counter-habitual response was required. Further, switch activity was 
augmented in MD and PFC neurons alike in response to scenarios of higher cognitive 
control demand. I also report that task state representation emerged earlier and stronger 
in the PFC at the beginning of the trial period and that task state representation in the 
MD was stronger at the end of the trial period during response selection. To this regard, 
the MD contained response-selective and probe-selective neurons for both valid and 
invalid variables compared to the PFC neurons, which were biased toward the invalid 
stimuli that signaled for the counter-habitual response. Lastly, I report that task state 




information was transmitted from the PFC to the MD during the cue and response period 
and bottom-up transmission from the MD to the PFC largely occurred at during the cue 
period and delay periods. Taken together, these data indicate that cognitive control state 
information is distributed across the MD and PFC network and response selection 
occurs in the MD with support from PFC input about cognitive control state. Therefore, 
the MD may perform response selection by comparing information from the PFC about 
the probability of requiring a nontarget response and information from the basal ganglia 
about the habitual response. This largely fits with prior research on MD function during 
spatial working memory task that showed similar encoding of task variables (Watanabe 
and Funahashi, 2004b, a; Watanabe et al., 2009; Watanabe and Funahashi, 2018), 
more involvement of the MD in the motor response selection than the PFC (Watanabe 
and Funahashi, 2004a; Watanabe et al., 2009; Parnaudeau et al., 2013; Bolkan et al., 
2017; Watanabe and Funahashi, 2018), and MD-PFC reciprocal functional connectivity 
during task performance (Parnaudeau et al., 2013; Bolkan et al., 2017; Schmitt et al., 
2017). However, as none these prior studies have recorded single neurons in the MD 
and PFC simultaneously during performance of a cognitive control task, my work adds 
previously unknown insight into the role of thalamocortical networks during cognitive 
control.  
In Chapter 3, I describe the effects of pharmacological NMDAR blockade on the 
distributed neural signals in the MD and PFC and relate them back to SZ-like cognitive 
control deficits. First, I report that following acute administration of PCP fewer single 
neurons exhibited task related activity and, although the basic activity patterns were 
largely intact in terms of the types of neural signals observed, the strength of activity 




powerfully suppressed the neural representation of task variables at the population level 
in PFC than MD, as evidenced by more pronounced reduction in population decoding 
accuracy following drug. This suggests that MD and PFC circuits are differentially 
dependent on NMDAR synaptic function. Third, task-related information transmission, 
both in the top-down and bottom-up directions, was decreased following PCP exposure 
compared to saline conditions. All of these changes in neural dynamics were also 
present in the saline condition relative to the drug-naïve condition, albeit to a lesser 
degree than in the drug condition. These data suggest that periodic and repeated 
exposure to PCP may induce chronic changes in PFC thalamocortical dynamics, 
perhaps by reducing coincident spiking in this network, a mechanism proposed in our 
prior report (Zick et al., 2018). Taken together, these data indicate that ongoing 
computations performed by MD-PFC thalamocortical network dynamics are dependent 
on NMDAR synaptic integrity. In the DPX task, the core functional requirement is that 
state information (countermand probability) encoded in PFC networks must override a 
habitual response to a stimulus. From that perspective, the breakdown of state 
representation in the MD-PFC network may contribute to the higher rate of errors on BX 
trials reflecting a failure of the countermand operation. Following an injection of PCP, the 
PFC is less able to encode cognitive control state and communicate this information with 
the MD, potentially releasing the habitual target response that is strongly encoded by 
MD neurons. That could occur if basal ganglia input to the MD, presumably encoding the 
habitual response, was not counterbalanced by equally strong input from the PFC, 
encoding the state-dependent response. In some respects, many symptoms of SZ 
reflect aberrant cognitive and perceptual habits, patterns of thought or percepts that 




a failure of PFC top-down control mechanisms involving the interplay between thalamic 
and cortical representations operating through the thalamus, consistent with some of the 
neural dynamics I have studied here. Our data fits with prior evidence in humans that 
activity in MD, and PFC, as well as functional connectivity between these areas is 
decreased in patients with SZ (Minzenberg et al., 2009; Welsh et al., 2010; Woodward et 
al., 2012; Anticevic et al., 2014b; Anticevic et al., 2014a; Tu et al., 2015). My data adds 
to our knowledge about the nature of MD-PFC network dysfunction at the level of spiking 
neurons as no prior studies have recorded neural activity in both areas simultaneously 
during performance of a cognitive control task following NMDAR blockade.  
 
Limitations 
There are a few limitations one should consider when assessing the results reported in 
my dissertation.  
First, SZ is a markedly complicated disease that results from an array of genetic 
and environmental factors that align in such a way to trigger the appearance of the 
disorder. At this time, monkey models are not easily genetically manipulated to 
determine the effects of genetic risk mutations on primate behavior and 
neurophysiology. Therefore, rodent genetic models have better construct validity that the 
monkey drug model I have employed, because they incorporate genetic mutations 
known to cause risk of SZ in humans, making it possible to investigate how genetic 
factors influence neural information processing. However, the link between genes and 
SZ is anything but simple. Many mutations increase risk, studying one or a few may not 
capture the full range of manifestations in the disorder, or indicate where the many 




between rodents and humans is limited, and it remains to be determined whether 
findings in rodents will ultimately succeed or fail to translate to humans. Nonhuman 
primate research, particularly of PFC mediated cognitive functions, is likely to remain an 
important stepping stone between rodent and human studies to understand how PFC 
malfunction could produce cognitive deficits in humans.  
Second, the number of individual animals studied in any single primate 
experiment is a significant limitation for neuropsychiatric relevant research, as individual 
differences between patients strongly contributes to disease manifestation and course. 
However, my dissertation work was able to replicate the NMDAR induced BX error 
pattern reported in a prior study from our lab using different animals (Blackman et al., 
2013), as well as several key aspects of neurophysiology, such as the presence of 
switch neurons coding cognitive state in prefrontal cortex (Blackman et al., 2016). 
Finally, there is evidence that altered NMDAR receptor function results from genetic 
mutations that increase SZ risk (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014), therefore, though not as strong as rodent genetic models, 
the NMDAR antagonist model I employed nonetheless may operate through neural 
mechanisms like those driving the human disease, and therefore provide construct 
(neural mechanism) as well as face (behavior) validity.  
 Third, one of the main motivations for targeting the MD-PFC neural network in 
my dissertation was the fact that the two structures are anatomically connected. I 
therefore recorded in the MD and PFC simultaneously in order to be able to analyze 
their functional interaction and relate it to cognitive performance. However, although I 
could recover recording locations using structural imaging, I do not know if the neurons I 




functional connectivity results indicating that information in one region is transmitted to 
the other region (perhaps across polysynaptic pathways) may be enough to answer my 
questions of how MD and PFC work together to produce cognitive control and how 
functional disconnection in this network could contribute to cognitive control deficits.  
 Fourth, I was not able to record the same neural ensembles both before an 
injection of PCP and after, and I could only evaluate differences in neural activity at the 
population level and cannot make direct statements about how NMDAR blockade 
affected individual neurons.  
 
Future directions 
First, the data collected for my dissertation work can be explored further to 
develop more precise theories of thalamocortical network dynamics for both cognitive 
control and cognitive deficits in patients with SZ. Future experiments could explore the 
influence of NMDAR blockade on cell-level spike synchrony (‘0-lag’ spiking) within and 
between neurons in the MD and PFC further, using recent analytical techniques 
developed in our lab (Zick et al., 2018). If the activity-dependent disconnection 
hypothesis I proposed is true, then chronic effects on neuronal activity, communication 
and effective synaptic connectivity should be cumulative following repeated PCP 
exposure in the MD-PFC network. It will be important to determine the time course of 
chronic effects. Theories of prefrontal network failure have focused on changes in 
parvalbumin positive (PV) GABAergic interneurons with downstream dysregulation of 
neural synchrony in PFC networks (Lisman et al., 2008). Therefore, it may be 
information to differentiate pyramidal and interneurons based on the waveforms of their 




blockade has different effects on these two classes of neurons. My dissertation focused 
on analyzing neural spiking activity, however, I also recorded local field potentials (LFPs) 
in the MD and PFC throughout the experiment. Therefore, there is much information 
about the synchronicity within each structure and between them to be gleaned from 
future analyses of these data.  
Second, the results of my dissertation work lead to new questions and provide a 
basis to design future experiments to address them. For one, recording neural activity 
simultaneously in the PFC, MD and the basal ganglia (specifically the substantia nigra or 
globus pallidus that provide input to the MD (Alexander et al., 1986; Haber and 
McFarland, 2001; Haber and Calzavara, 2009) could elucidate the mechanisms of 
neural competition involving all three structures between populations encoding the 
habitual and state-dependent behavioral responses that I have proposed. I have found 
that cognitive control state signals are weakened by NMDAR receptor blockade. 
Presumably this would make it more likely that neural populations coding the habitual 
response would win the neural competition, leading to BX errors. However, it remains to 
be determined whether competition between these two neural populations can explain 
BX errors on a trial-by-trial basis, or the extent to which MD mediates this competition 
between neural signals originating in PFC and basal ganglia.  
Third, further understand of the pathophysiology underlying cognitive deficits 
could inform the development of future therapies targeting the MD-PFC network. This 
thalamocortical network may provide a useful inroad to modulating PFC function, since 
the MD is a relatively restricted structure where electrical stimulation, or genetic 
therapies, could have wide-ranging influence on prefrontal cortex. The efficacy of such 




correlated with increased thalamocortical functional connectivity in SZ patients (Ramsay 
et al., 2017). Developing better therapeutics for patients with SZ will require further 
exploration and understanding of the pathophysiology underlying the complex 
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